List of patient-reported quality of life surveys

6193: 6014: 4204: 3486: 2540: 2053: 335:(NHP) is a general patient-reported outcome designed to measure a patient's view of their own health status, in a number of areas. It can be completed in 5 minutes. It was developed in 1975 and current copyright belongs to Galen Research. Clinical research studies where the NHP has been utilized include investigations into 5889:"Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial" 135:

The Parents' Index of Quality of Life in Atopic Dermatitis (PiQOL-AD) measures the impact that atopic dermatitis has on quality of life, from the parents' perspective. It has 28 items and was developed simultaneously in the United Kingdom, The Netherlands, Germany, Italy, Spain, France and the United

288:

The Assessment of Quality of Life scales (AQoL) were psychometrically developed and refined over the past 30 years and are reliable and well-validated. There are 4 instruments available; the AQoL-8D is the most comprehensive as it assesses HR-QoL across 8 domains - independent living, happiness,

2110:

Chatzimichalis, Michail; Epprecht, Lorenz; Weder, Stefan; Shaul, Chanan; Engle Folchert, Kristi J.; Machala, Maria C.; Goosmann, Madeline M.; Naville, Marc; Zhu, Angela; Röösli, Christof; Lee, Daniel J.; Cass, Stephen P.; Briggs, Robert; Huber, Alexander M.; Bächinger, David (2019). "English

2215:

Bächinger, David; Takagi, Daiki; Yamada, Hiroyuki; Teraoka, Masato; Okada, Masahiro; Hyodo, Jun; Röösli, Christof; Huber, Alexander M.; Hato, Naohito (2019). "Japanese translation, cross-cultural adaption and multicentre validation of the Zurich chronic middle ear inventory (ZCMEI-21-Jap)".

6455:

Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, et al. (August 2010). "Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey".

311:

is a generalised health-related quality of life measure which was developed in 1991 by the EuroQol Group. It has five standard dimensions and has been translated into over 60 languages. The EuroQoL has been extensively used in clinical trials, investigating a range of topics including

548:(CAMPHOR) is a disease-specific measure which assesses quality of life of patients with pulmonary hypertension. It was developed in 2006 and has since been translated into fourteen different languages. The CAMPHOR has been utilized in clinical trials which investigate the effects of 447:. The Kidney Disease Quality of Life (KD-QOL) Instrument was developed in 1994 by the RAND corporation. It has been utilized in studies investigating thirst and xerostomia in maintenance hemodialysis patients, different types of dialysis and quality of life in hemodialysis patients. 204:. The Living with Chronic Obstructive Pulmonary Disease questionnaire (LCOPD) has 22 yes or no questions and measures a patient's quality of life. It has been translated into 14 languages and also been used in an investigation of fatigue, sleep loss and mood for patients with COPD. 530:(RAQoL) questionnaire determines the effect rheumatoid arthritis has on a patient's quality of life. The RAQoL has 30 items with a yes and no response format and takes about six minutes to complete. The RAQoL has been used in clinical studies in order to confirm the efficacy of 2953:

Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA (December 2013). "Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis".

4808:

Moock J, Friedrich N, Völzke H, Spielhagen C, Nauck M, Koltowska-Häggström M, et al. (October 2011). "Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort".

246:. The Epilepsy Surgery Inventory 55 (ESI-55) was developed at the University of California and covers eleven health concepts. It has been used in clinical studies to investigate life pre and post surgery, psychiatric disorders and the subjective handicap of epilepsy. 6769:"Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)" 421:(RGHQoL) was developed in 1998 by Galen Research in order to assess the impact recurrent genital herpes has on quality of life. It has been used in clinical trials investigating famciclovir, suppressive antiviral therapy and patient perspectives and quality of life. 594:. The Patient-Reported Impact of Scars Measure (PRISM) was developed in 2010 by Galen Research and was the first scar specific patient-reported outcome measure. It consists of two scales: one with 24 items for quality of life, and one with 13 items for symptoms. 56:. The Quality of Life of Carers of Alzheimer's Disease Patients (ACQLI) is a measure which assesses the quality of life of people who care for Alzheimer's disease patients. It was developed in 1997 by Galen Research and has been used in studies investigating 4764:

Wirén L, Whalley D, McKenna S, Wilhelmsen L (February 2000). "Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis".

277:(U-FIS) was developed in 2009 by Galen Research primarily for the measurement of multiple sclerosis related fatigue. It has been recommended for use in determining fatigue by an independent clinical research study and translated into eight languages. 2164:

Ralli, Massimo; Quaranta, Nicola; Canale, Andrea; Röösli, Christof; Milella, Claudia; De Robertis, Valentina; De Soccio, Giulia; Greco, Antonio; Ralli, Giovanni; Albera, Roberto; De Vincentiis, Marco; Huber, Alexander M.; Bächinger, David (2019).

6027:

McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J (February 2006). "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension".

580:(PsAQoL) measures the effect that psoriatic arthritis has on a patient's quality of life. It is a self-administered, 20-item questionnaire that takes about three minutes to complete. It has been translated into 30 languages and used to evaluate 5105:

Cortés-Sanabria L, Paredes-Ceseña CA, Herrera-Llamas RM, Cruz-Bueno Y, Soto-Molina H, Pazarín L, et al. (November 2013). "Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis".

2066:

Bächinger D, Röösli C, Ditzen B, Huber AM (October 2016). "Development and validation of the Zurich chronic middle ear inventory (ZCMEI-21): an electronic questionnaire for assessing quality of life in patients with chronic otitis media".

2166: 2754:

da Conceição PO, Nascimento PP, Mazetto L, Alonso NB, Yacubian EM, de Araujo Filho GM (May 2013). "Are psychiatric disorders exclusion criteria for video-EEG monitoring and epilepsy surgery in patients with mesial temporal sclerosis?".

430: 6206:

Tay EL, Papaphylactou M, Diller GP, Alonso-Gonzalez R, Inuzuka R, Giannakoulas G, et al. (June 2011). "Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy".

5317:

Mérelle SY, Sorbi MJ, van Doornen LJ, Passchier J (February 2008). "Migraine patients as trainers of their fellow patients in non-pharmacological preventive attack management: short-term effects of a randomized controlled trial".

5804:"Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)" 2553:

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE (May 2006). "Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials".

1715:

Lambert J, Bostoen J, Geusens B, Bourgois J, Boone J, De Smedt D, Annemans L (January 2011). "A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results".

4969:

Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, Mattsson AF, Svensson D, Westberg B, Luger A (January 2008). "Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)".

1929:

Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC (May 2011). "Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis".

384:

The Health Utilities Index measures health status, health-related quality of life and produces utility scores. It was developed by Health Utilities Inc. in Canada. It has been used in clinical studies investigating

409:

The Herpes Symptom Checklist (HSC) was developed alongside the HOIQ in order to assess daily symptoms of genital herpes outbreaks. It was also used in an Australian clinical trial which tested the effectiveness of

252:. The National Eye Institute Visual Function (VFQ-25) is a 25-item questionnaire designed to assess eye health, intended for use in clinical studies. The survey has been utilized in clinical studies investigating 214:(QLDS) assesses the impact that depression has on a patient's quality of life. It was developed by Galen Research in 1992 and was funded by Lilly Industries. Studies utilizing the QLDS include investigations into 2882:

Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. (May 2011). "Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration".

5501:

Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F (April 2013). "Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients".

3743:

Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, et al. (October 2011). "Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients".

4590:

Bartlett BL, Tyring SK, Fife K, Gnann JW, Hadala JT, Kianifard F, Berber E (October 2008). "Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial".

3244:

Kaplan RM, Patterson TL, Kerner DN, Atkinson JH, Heaton RK, Grant I (August 1997). "The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center".

406:

The Herpes Outbreak Impact Questionnaire (HOIQ) is designed to determine the impact of recurrent genital herpes outbreaks on a patient's life. Its efficacy has been tested in an Australian clinical trial.

461:

and developed by Galen Research, as part of an international research study which was conducted in eight countries, with initial work conducted in the UK and US. It has been used to assess the effect of

566:(PSORIQOL) was the first psoriasis specific quality of life questionnaire. It was developed in 2003 by Galen Research and has been translated into 10 languages. The PSORIQOL has been recognized by the 5472:"Patient-Reported Treatment Satisfaction, Reasons for Therapy Change, and Health-Related Quality of Life at Baseline from the Trial To Evaluate Patient OutComes, Safety and Tolerability of Fingolimod" 527: 4081:

van Straten A, de Haan RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GA (November 1997). "A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30)".

3288:

Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL (1997). "Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients".

6683:

Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (February 2009). "The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus".

4547:

Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, Thorsen H (February 1998). "The international development of the RGHQoL: a quality of life measure for recurrent genital herpes".

1434:

McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. (February 2005). "International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)".

437:

has on adult patients. The QoL-AGHDA has been used in numerous clinical practice and research studies worldwide and is also utilized by the Pfizer International Metabolic Database (KIMS) and the

5233:

Garcia-Monco JC, Foncea N, Bilbao A, Ruiz de Velasco I, Gomez-Beldarrain M (August 2007). "Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients".

5440: 6242:

Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, et al. (August 2008). "Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension".

788:

Jitta DJ, DeJongste MJ, Kliphuis CM, Staal MJ (January 2011). "Multimorbidity, the predominant predictor of quality-of-life, following successful spinal cord stimulation for angina pectoris".

1181:

Kim MA, Ye YM, Park JW, Lee JH, Lee SK, Kim CW, et al. (2013). "A computerized asthma-specific quality of life: a novel tool for reflecting asthma control and predicting exacerbation".

4356:

Ebrahim S, Parshuram C (March 2015). "Comparison of utility scores from the Visual Analog Scale and Health Utilities Index 3 in children following pediatric intensive care unit admission".

4846:"Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study" 3499:

Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, et al. (December 2014). "Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD".

2798:

Monteiro E, Osório F, Veriano A, Molina RS, Funayama SS, Terra VC, et al. (July 2012). "Validation of the Subjective Handicap of Epilepsy (SHE) in Brazilian patients with epilepsy".

296:

The Quality of Well-Being Scale (QWB) was developed in the 1970s, and a self-administered version called the QWB-SA was published in 1996. The QWB has been used in studies investigating

477: 6602:

for "A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)" at

2111:

translation and validation of the Zurich chronic middle ear inventory (ZCMEI‐21‐E) assessing quality of life in chronic otitis media: A prospective international multicentre study".

1759:

Bostoen J, Bracke S, De Keyser S, Lambert J (November 2012). "An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial".

2320:

López-Campos JL (2009). "" [Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments].

831:

Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, et al. (July 2013). "Effects of ivabradine and ranolazine in patients with microvascular angina pectoris".

866:

Andréll P, Ekre O, Grip L, Währborg P, Albertsson P, Eliasson T, et al. (March 2011). "Fatality, morbidity and quality of life in patients with refractory angina pectoris".

3542:

Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E (February 2014). "Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective".

5441:"Study design of a non-interventional registry study to establish long-term safety and pharmaco-economic data on fingolimod (Gilenya®) in multiple sclerosis patients (PANGAEA)" 2918:

Kirwan C, Lanigan B, O'Keefe M (2012). "Vision-related quality of life assessment using the NEI-VFQ-25 in adolescents and young adults with a history of congenital cataract".

704:

Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N (March 2012). "Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?".

362:. It was designed for use in clinical practice, research, health policy evaluations and population surveys. It has been used in numerous studies including ones investigating 3341:

Frosch DL, Kaplan RM, Ganiats TG, Groessl EJ, Sieber WJ, Weisman MH (February 2004). "Validity of self-administered quality of well-being scale in musculoskeletal disease".

3164:

Maxwell A, Özmen M, Iezzi A, Richardson J (December 2016). "Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data".

3787:

Aydemir G, Tezer MS, Borman P, Bodur H, Unal A (June 2006). "Treatment of tinnitus with transcutaneous electrical nerve stimulation improves patients' quality of life".

567: 438: 188:. The Zurich Chronic Middle Ear Inventory (ZCMEI-21) has 21 questionnaires with answers as a 5-point Likert scale and measures health-related quality of life in chronic 418: 5971:"Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses" 545: 6728:"Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature" 2591:"Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression" 66:. The Seattle Angina Questionnaire (SAQ) measures five dimensions of coronary disease and consists of 19 items. The SAQ has been utilized in studies investigating 3411: 2997:

Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B (October 2009). "The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)".

2460:

Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA (2002). "Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression".

952:"Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis" 6324:, Van Assche D (August 2003). "Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials". 5361:

Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ (September 2009). "The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)".

2355:

Amir M, Lewin-Epstein N, Becker G, Buskila D (October 2002). "Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel".

5448: 4885:

Badia X, Lucas A, Sanmartí A, Roset M, Ulied A (December 1998). "One-year follow-up of quality of life in adults with untreated growth hormone deficiency".

2259:

Weldam SW, Schuurmans MJ, Liu R, Lammers JW (May 2013). "Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review".

1226:"[A randomised clinical trial to evaluate the effectiveness of an educational intervention developed for adult asthmatics in a primary care centre]" 1003:"Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study" 181:. The Family Disruption Measure for Chickenpox was developed in 1994 by Galen Research. It has been used in a study investigating rotavirus gastroenteritis. 6615:

Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A (May 2010). "The patient-reported impact of scars measure: development and validation".

4930:"The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy" 344: 144: 2167:"Cross-cultural Adaption and Validation of the Zurich Chronic Middle Ear Inventory Translated into Italian (ZCMEI-21-It)—a Prospective Multicenter Study" 6150:"Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension" 5666: 1044:"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study" 317: 3577:

Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (May 1981). "The Nottingham Health Profile: subjective health status and medical consultations".

2398:

McKenna SP, Hunt SM (October 1992). "A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS".

621: 4116:

Hulsebos RG, Beltman FW, dos Reis Miranda D, Spangenberg JF (1991). "Measuring quality of life with the sickness impact profile: a pilot study".

1479:"Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life" 1802:

Moed H, Yang Q, Oranje AP, Panda S, Van Der Wouden JC (2012). "Different strategies for using topical corticosteroids for established eczema".

89: 4718:

Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC (October 2001). "Patients' perspectives on the burden of recurrent genital herpes".

3228: 201: 480:(PRIMUS) was developed in 2009 by Galen Research and funded by Novartis Pharmaceuticals. The PRIMUS has been used to assess the efficacy of 5013:

Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (October 1994). "Development of the kidney disease quality of life (KDQOL) instrument".

673:

for "Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-2)" at

600:. The Systemic Lupus Erythematosus Quality of Life measure (L-QoL or SLEQoL) was published in 2009 by Galen Research and was funded by the 691:

for "Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-3)" at

6393: 3042:"Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties" 577: 274: 237: 211: 563: 5664:

Abbas M, Schwartz ME, Smith FJ, McLean WH, Hull PR (2014). "PCQoL: A Quality of Life Assessment Measure for Pachyonychia Congenita".

196:. It has originally been developed in German and has been translated into several languages, including English, Italian and Japanese. 3856:

Ware JE, Sherbourne CD (June 1992). "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection".

454: 336: 5930:"Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis" 5190:

Patrick DL, Hurst BC, Hughes J (2000). "Further development and testing of the migraine-specific quality of life (MSQOL) measure".

4628:"Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection" 6277:

McKenna SP, Lebwohl M, Kahler KN (June 2005). "Development of the US PSORIQoL: a psoriasis-specific measure of quality of life".

1134:"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials" 6321: 115:

in Ontario, Canada and was published in 1992. It has since been used as a comparison tool as well as a tool in clinical trials.

1224:

Cano Fuentes G, Dastis Bendala C, Morales Barroso I, Manzanares Torné ML, Fernández Gregorio A, Martín Romana L (March 2014).

1060: 1043: 5639:"HERO:Hydroxychloroquine Effectiveness in Reducing Symptoms of hand OA, a randomised, double-blind, placebo-controlled trial" 5143:"Quality of life and correlation with musculoskeletal problems, hand disability and depression in patients with hemodialysis" 749:"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease" 151:

for patients over the age of 16. The QoLIAD has also been utilized in studies looking into educational intervention, topical

517: 175:. It was published in 1998. It has been validated for use in assessing other non-surgical treatments for issues of the knee. 140:. and also in a research study regarding health-related quality of life measurement in children in Ibero-American countries. 4434:"Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist" 3899:

Abulhasan M, Elshazly TA, Eida M, Albadry A (September 2013). "Giardia intestinalis in patients with nonulcer dyspepsia".

1273:

Santino, Thayla A.; Chaves, Gabriela Ss; Freitas, Diana A.; Fregonezi, Guilherme Af; Mendonça, Karla Mpp (25 March 2020).

136:

States. It has been utilised in several research studies investigating the treatment of paediatric atopic dermatitis with

4516:"PIN5 Patient and Clinician Perceived Benefit of Early Consumption of Famciclovir for the Treatment of Herpes Outbreaks" 1973:

McKenna SP, Hunt SM (March 1994). "A measure of family disruption for use in chickenpox and other childhood illnesses".

597: 5587:"Treating painful hand osteoarthritis using low dose oral prednisolone- assessing short-term pain and imaging outcomes" 655:

for "Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease" at

236:(DHP) was developed in 1996 by Isis Outcomes. It has been officially adapted into 29 languages and was selected by the 5471: 5058:"Study on the clinical significance and related factors of thirst and xerostomia in maintenance hemodialysis patients" 3419: 601: 5445:

5th Joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis

1569:"Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug" 1610:"Health-related quality of life measurement in children and adolescents in Ibero-American countries, 2000 to 2010" 5714:"The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument" 434: 426: 332: 92:

questionnaire (ASQoL) was developed Galen Research and published in 2003. It has been used in the evaluation of

520:(PCQoL) was developed in 2012 to determine the effect Pachyonychia Congenita has on a patient's quality of life. 378: 119: 33: 5613:"An open label study to assess the effectiveness of oral methotrexate in reducing pain in knee osteoarthritis" 147:(QoLIAD) measures the impact that atopic dermatitis has on a given patient's quality of life. It is a 25 item 5470:

Cascione M, Wynn D, Agashivala N, McCague K, Pestreich L, Schofield L, Kim E, Barbato L (12 February 2013).

3117:"Validity and reliability of the Assessment of Quality of Life (AQoL)-8D multi-attribute utility instrument" 513: 233: 67: 6429: 6192: 6013: 5638: 5612: 5586: 4203: 3485: 2539: 2052: 1372: 6817: 4219:"The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies" 3297: 541: 494:. The Osteoarthritis Quality of Life (OAQOL) questionnaire was published in 2008 and was developed at the 371: 85: 53: 44:, and may be used to evaluate patient satisfaction, symptoms, disease state, or psychological well-being. 2638:

Vickrey BG (1993). "A procedure for developing a quality-of-life measure for epilepsy surgery patients".

1528:"Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children" 207: 5763:"Literacy levels required to complete routinely used patient-reported outcome measures in rheumatology" 3985:"Associations of sleep disturbance symptoms with health-related quality of life in Parkinson's disease" 2708: 1403:"Psk8 Impact of Atopic Dermatitis on the Quality-Of-Life of Parents of Children with Atopic Dermatitis" 4675:

Spencer B, Leplège A, Ecosse E (June 1999). "Recurrent genital herpes and quality of life in France".

3704:"Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients" 498:, the University of Lancashire and Galen Research. It has been used in clinical studies investigating 3302: 523: 390: 363: 253: 3830: 573: 495: 386: 112: 6548:

Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, et al. (June 2007).

6708: 6603: 6481: 6349: 6302: 6053: 5743: 5691: 5527: 5421: 5386: 5343: 5258: 5215: 5172: 5087: 5038: 4995: 4910: 4790: 4743: 4700: 4572: 4381: 4297: 4248: 4141: 3881: 3812: 3769: 3524: 3323: 3270: 3189: 3022: 2979: 2823: 2780: 2736: 2663: 2380: 2241: 2197: 2146: 2092: 1955: 1837: 1829: 1784: 1741: 1508: 1459: 1330:

Meads DM, McKenna SP, Doward LC, Pokrzywinski R, Revicki D, Hunter C, Glendenning GA (May 2010).

1206: 813: 729: 692: 674: 656: 507: 473: 313: 122:(ALIS) measure was developed in 2010 by Galen Research. It has been translated into 16 languages. 5887:

Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, et al. (January 2005).

5278:"A randomized trial on the effects of regular water intake in patients with recurrent headaches" 4032:

Gilson BS, Gilson JS, Bergner M, Bobbit RA, Kressel S, Pollard WE, Vesselago M (December 1975).

3040:

Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF, Terwee CB, Kwakkel G (August 2012).

901:

Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. (January 2003).

747:

Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD (February 1995).

470:, regular water intake and using migraine patients as trainers in preventive attack management. 6794: 6749: 6700: 6632: 6579: 6530: 6473: 6404: 6341: 6294: 6259: 6224: 6181: 6130: 6045: 6002: 5951: 5910: 5833: 5784: 5735: 5683: 5568: 5519: 5378: 5335: 5299: 5250: 5207: 5164: 5123: 5079: 5030: 4987: 4951: 4902: 4867: 4826: 4782: 4735: 4692: 4657: 4608: 4564: 4496: 4475:"The development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire" 4455: 4373: 4338: 4289: 4240: 4192: 4133: 4098: 4063: 4014: 3965: 3916: 3873: 3804: 3761: 3725: 3684: 3643: 3594: 3559: 3516: 3474: 3393: 3358: 3315: 3262: 3224: 3181: 3146: 3071: 3014: 2971: 2935: 2900: 2864: 2815: 2772: 2728: 2655: 2620: 2571: 2528: 2477: 2442: 2415: 2372: 2337: 2276: 2233: 2189: 2138: 2084: 2041: 1990: 1947: 1911: 1776: 1733: 1631: 1590: 1567:

Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, et al. (August 2002).

1549: 1500: 1451: 1353: 1312: 1294: 1255: 1198: 1163: 1114: 1065: 1024: 983: 932: 883: 848: 805: 770: 721: 270: 172: 168: 127: 3934:

Cuevas BT, Hughes DC, Parma DL, Treviño-Whitaker RA, Ghosh S, Li R, Ramirez AG (April 2014).

6784: 6776: 6739: 6692: 6663: 6624: 6569: 6561: 6520: 6512: 6465: 6333: 6286: 6251: 6216: 6171: 6161: 6120: 6110: 6037: 5992: 5982: 5941: 5900: 5860: 5823: 5815: 5774: 5725: 5675: 5558: 5511: 5413: 5370: 5327: 5289: 5242: 5199: 5154: 5115: 5069: 5022: 4979: 4941: 4894: 4857: 4818: 4774: 4727: 4684: 4647: 4639: 4600: 4556: 4527: 4486: 4445: 4412: 4365: 4328: 4279: 4230: 4182: 4172: 4125: 4090: 4053: 4045: 4004: 3996: 3955: 3947: 3908: 3865: 3796: 3753: 3715: 3674: 3633: 3625: 3586: 3551: 3508: 3464: 3454: 3385: 3350: 3307: 3254: 3216: 3173: 3136: 3128: 3061: 3053: 3006: 2963: 2927: 2892: 2854: 2807: 2764: 2720: 2647: 2610: 2602: 2563: 2518: 2508: 2469: 2407: 2364: 2329: 2268: 2225: 2181: 2128: 2120: 2076: 2031: 2021: 1982: 1939: 1901: 1868: 1818: 1807: 1768: 1725: 1695: 1662: 1621: 1580: 1539: 1490: 1443: 1414: 1343: 1302: 1286: 1245: 1237: 1190: 1153: 1145: 1104: 1096: 1055: 1014: 973: 963: 922: 914: 875: 840: 797: 760: 713: 359: 5802:

Dougados M, Kissel K, Sheeran T, Tak PP, Conaghan PG, Mola EM, et al. (January 2013).

5547:"Development and validation of a needs-based quality of life instrument for osteoarthritis" 1001:

Davis JC, Revicki D, van der Heijde DM, Rentz AM, Wong RL, Kupper H, Luo MP (August 2007).

903:"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis" 570:

as a suitable tool for assessing disease impact and has also been used in clinical studies.

6652:"Pss36 Development and Validation of the Patient-Reported Impact of Scars Measure (Prism)" 4317:"Validity of utility measures for women with urge, stress, and mixed urinary incontinence" 4266:

Davis EM, Lynd LD, Grubisic M, Kopec JA, Sayre EC, Cibere J, et al. (December 2013).

3702:

Johansen KL, Finkelstein FO, Revicki DA, Evans C, Wan S, Gitlin M, Agodoa IL (June 2012).

950:

van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, et al. (2009).

301: 152: 79: 6501:"Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis" 3443:"Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder" 1857:"Psk6 Belgian Drug Utilisation Study of Elidel® in Routine Practice in Atopic Dermatitis" 1477:

McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D (March 2006).

1085:"Bone mineral density improvement in spondyloarthropathy after treatment with etanercept" 1083:

Marzo-Ortega H, McGonagle D, Haugeberg G, Green MJ, Stewart SP, Emery P (October 2003).

6789: 6768: 6574: 6549: 6525: 6500: 6176: 6149: 6125: 6098: 5997: 5970: 5828: 5803: 4652: 4627: 4058: 4033: 4009: 3984: 3960: 3935: 3679: 3662: 3638: 3613: 3469: 3442: 3141: 3116: 3066: 3041: 2651: 2523: 2496: 2036: 2009: 1307: 1274: 1250: 1225: 1109: 1084: 978: 951: 927: 902: 491: 458: 444: 398: 340: 25: 6668: 6651: 4417: 4400: 4187: 4160: 2724: 2615: 2590: 2473: 2333: 1873: 1856: 1700: 1683: 1667: 1651:"Psk6 Interpreting Scores on the Quality of Life Index for Atopic Dermatitis (Qoliad)" 1650: 1419: 1402: 1158: 1133: 6811: 6337: 6290: 5695: 5425: 5331: 5246: 5203: 5091: 4898: 4862: 4845: 4778: 4491: 4474: 4450: 4433: 4161:"The Health Utilities Index (HUI): concepts, measurement properties and applications" 4000: 3869: 3773: 3757: 3590: 3389: 3208: 2411: 2368: 1986: 1943: 1772: 1495: 1478: 1132:

Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK (February 1992).

801: 765: 748: 733: 717: 367: 193: 148: 57: 37: 6712: 6485: 6353: 6306: 6148:

Chen H, Rosenzweig EB, Gotzkowsky SK, Arneson C, Nelsen AC, Bourge RC (March 2013).

6057: 5819: 5747: 5730: 5713: 5347: 5219: 5176: 5042: 4999: 4914: 4794: 4747: 4704: 4576: 4385: 4301: 4252: 3885: 3816: 3528: 3327: 3026: 2827: 2740: 2681: 2667: 2384: 2245: 2201: 2150: 2096: 1788: 1745: 1512: 1463: 1210: 817: 6367: 6071: 5531: 5390: 5262: 4145: 3274: 3193: 3089: 2294: 2272: 1959: 1822: 1290: 549: 503: 499: 485: 325: 189: 185: 164: 156: 137: 41: 6744: 6727: 6598: 5946: 5929: 5852: 5779: 5762: 3983:

Avidan A, Hays RD, Diaz N, Bordelon Y, Thompson AW, Vassar SD, Vickrey BG (2013).

2784: 1526:

Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, et al. (July 2002).

844: 687: 669: 651: 6628: 6220: 5119: 2983: 2931: 2843:"Development of the 25-item National Eye Institute Visual Function Questionnaire" 2589:

Dunner DL, Kwong WJ, Houser TL, Richard NE, Donahue RM, Khan ZM (February 2001).

2185: 1608:

Rajmil L, Roizen M, Psy AU, Hidalgo-Rasmussen C, Fernández G, Dapueto JJ (2012).

879: 381:. It consists of 136 items and has been adapted for strokes, and ex-ICU patients. 6499:

McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (February 2004).

4928:

Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (March 2005).

3441:

Desroziers K, Aballéa S, Maman K, Nazir J, Odeyemi I, Hakimi Z (November 2013).

2859: 2842: 2811: 2768: 1906: 1889: 1241: 531: 411: 249: 215: 5545:

Keenan AM, McKenna SP, Doward LC, Conaghan PG, Emery P, Tennant A (June 2008).

4822: 4532: 4515: 4333: 4316: 4034:"The sickness impact profile. Development of an outcome measure of health care" 3555: 3311: 2497:"Duloxetine in the treatment of major depressive disorder: an open-label study" 2495:

Hudson JI, Perahia DG, Gilaberte I, Wang F, Watkin JG, Detke MJ (August 2007).

1684:"Psn12 Quality-Of-Life in Patients Suffering from Atopic Dermatitis in Germany" 1626: 1609: 1348: 1331: 6469: 6041: 4844:

Gilet H, Chachuat A, Viala-Danten M, Auzière S, Koltowska-Häggström M (2010).

4688: 4604: 4560: 4235: 4218: 4094: 3951: 3912: 3800: 3512: 3258: 3177: 3132: 3057: 2967: 2229: 2080: 1811: 1729: 1447: 585: 581: 553: 535: 481: 467: 257: 219: 178: 97: 93: 75: 71: 6550:"Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis" 5515: 5417: 5374: 4731: 4369: 4315:

Harvie HS, Shea JA, Andy UU, Propert K, Schwartz JS, Arya LA (January 2014).

3459: 3010: 2841:

Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (July 2001).

1298: 431:

The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure

6696: 6565: 6516: 6166: 5679: 5294: 5277: 5276:

Spigt M, Weerkamp N, Troost J, van Schayck CP, Knottnerus JA (August 2012).

5159: 5142: 4049: 1585: 1568: 559: 321: 260: 223: 6798: 6753: 6704: 6636: 6583: 6534: 6477: 6345: 6298: 6263: 6228: 6185: 6134: 6049: 6006: 5987: 5955: 5914: 5865: 5837: 5788: 5687: 5572: 5523: 5382: 5339: 5303: 5254: 5211: 5168: 5127: 5083: 4991: 4955: 4906: 4871: 4830: 4786: 4739: 4696: 4661: 4612: 4500: 4459: 4377: 4342: 4293: 4244: 4196: 4177: 4018: 3969: 3920: 3808: 3765: 3729: 3563: 3520: 3478: 3397: 3362: 3185: 3150: 3075: 3018: 2975: 2939: 2904: 2868: 2819: 2776: 2732: 2624: 2575: 2532: 2513: 2481: 2446: 2419: 2376: 2341: 2280: 2237: 2193: 2142: 2088: 2045: 2026: 1951: 1890:"Questionnaire on the perceptions of patients about total knee replacement" 1780: 1737: 1635: 1594: 1553: 1504: 1455: 1357: 1316: 1259: 1202: 1118: 1100: 1069: 1028: 987: 936: 887: 852: 809: 725: 6650:

Wilburn J, McKenna SP, Brown B, Solomon M, McGrouther DA, Bayat A (2009).

6255: 5739: 5034: 4568: 4284: 4267: 4137: 4102: 4067: 3877: 3688: 3647: 3629: 3598: 3319: 3266: 3220: 2659: 1994: 1915: 1826:. If this is an intentional citation to a retracted paper, please replace 1544: 1527: 1167: 774: 4946: 4929: 4643: 3720: 3703: 2896: 2606: 2567: 2008:

Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB (February 2009).

450: 348: 243: 229: 21: 6115: 3663:"Measuring health status: a new tool for clinicians and epidemiologists" 2133: 1149: 918: 5026: 4129: 463: 264: 111:

The Adult Asthma Quality of Life Questionnaire (AQLQ) was developed at

6780: 5905: 5888: 5563: 5546: 5141:

Fidan F, Alkan BM, Tosun A, Altunoğlu A, Ardıçoğlu Ö (February 2016).

5074: 5057: 4401:"Pin41 Development of the Herpes Outbreak Impact Questionnaire (Hoiq)" 4268:"Responsiveness of health state utility values in knee osteoarthritis" 3354: 2124: 1194: 1019: 1002: 5928:

Bejarano V, Conaghan PG, Quinn MA, Saleem B, Emery P (October 2010).

4983: 1061:

10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H

280: 103: 63: 29: 5439:

van Lokven T, Kempcke R, Ziemssen T, Meergans M (October 20, 2011).

433:(QoL-AGHDA) was developed by Galen Research and measures the effect 6403:. National Institute for Health and Care Excellence. Archived from 3614:"Use of the Nottingham Health Profile with patients after a stroke" 1332:"Development and validation of the Asthma Life Impact Scale (ALIS)" 1042:

Marzo-Ortega H, McGonagle D, O'Connor P, Emery P (September 2001).

968: 5712:

de Jong Z, van der Heijde D, McKenna SP, Whalley D (August 1997).

591: 355: 308: 4626:

Patel R, Tyring S, Strand A, Price MJ, Grant DM (December 1999).

1855:

Lecomte P, Lambert J, Degreef H, Lesaffre E, De Backer M (2006).

289:

mental health, coping, relationships, self worth, pain, senses (

3831:"36-Item Short Form Survey from the RAND Medical Outcomes Study" 5853:"Efficacy of tocilizumab in patients with rheumatoid arthritis" 377:

The Sickness Impact Profile (SIP) was developed in 1997 by the

1483:

Journal of the European Academy of Dermatology and Venereology

297: 5969:

McKenna SP, Ratcliffe J, Meads DM, Brazier JE (August 2008).

3936:"Motivation, exercise, and stress in breast cancer survivors" 1373:"Further Developments of the Asthma Life Impact Scale (ALIS)" 3376:

Brooks R (July 1996). "EuroQol: the current state of play".

2595:

Primary Care Companion to the Journal of Clinical Psychiatry

1682:

Ehlken B, Kugland B, Schramm B, Quednau K, Berger K (2003).

4473:

Doward LC, McKenna SP, Meads DM, Kahler K, Frech F (2009).

4159:

Horsman J, Furlong W, Feeny D, Torrance G (October 2003).

1888:

Dawson J, Fitzpatrick R, Murray D, Carr A (January 1998).

290: 3989:

The Journal of Neuropsychiatry and Clinical Neurosciences

3667:

The Journal of the Royal College of General Practitioners

6726:

Castelino M, Abbott J, McElhone K, Teh LS (April 2013).

6320:

McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL,

5707: 5705: 4217:

Furlong WJ, Feeny DH, Torrance GW, Barr RD (July 2001).

604:. It has been evaluated in two medical research studies. 568:

National Institute for Health and Care Excellence (NICE)

439:

National Institute for Health and Care Excellence (NICE)

2010:"The impact of rotavirus gastroenteritis on the family" 488:. and has been translated into ten different languages. 478:

Patient Reported Outcome Indices for Multiple Sclerosis

393:

and children who have been admitted to intensive care.

5761:

Adams J, Chapman J, Bradley S, Ryan SJ (March 2013).

1894:

The Journal of Bone and Joint Surgery. British Volume

171:(OKS) is owned by Isis Outcomes and was developed at 4934:

The Journal of Clinical Endocrinology and Metabolism

1649:Meads DM, McKenna SP, Doward LC, Hampson N (2005). 4432:Meads DM, McKenna SP, Bonney MA, Bloch MT (2009). 3115:Richardson J, Iezzi A, Khan MA, Maxwell A (2014). 2920:Journal of Pediatric Ophthalmology and Strabismus 2885:Investigative Ophthalmology & Visual Science 2707:Selai CE, Elstner K, Trimble MR (January 2000). 1183:International Archives of Allergy and Immunology 419:Recurrent genital herpes quality of life measure 240:for their Long Term Conditions PROM Pilot Study. 4514:Twiss J, Mckenna S, Bloch M, Bonney MA (2011). 2709:"Quality of life pre and post epilepsy surgery" 2682:"Epilepsy Surgery Inventory 55 Survey (ESI-55)" 2433:Baca Baldomero E, Cervera Enguix S (2003). "". 546:Cambridge Pulmonary Hypertension Outcome Review 358:is a survey of general health developed by the 5056:Fan WF, Zhang Q, Luo LH, Niu JY, Gu Y (2013). 4759: 4757: 1573:The Journal of Allergy and Clinical Immunology 4321:American Journal of Obstetrics and Gynecology 753:Journal of the American College of Cardiology 60:and the effects of pharmacological treatment. 8: 6099:"Inhaled treprostinil: a therapeutic review" 6097:Channick RN, Voswinckel R, Rubin LJ (2012). 5447:. Amsterdam, the Netherlands. Archived from 3661:Hunt SM, McEwen J, McKenna SP (April 1985). 3618:Journal of Epidemiology and Community Health 1275:"Breathing exercises for adults with asthma" 5147:International Journal of Rheumatic Diseases 1932:International Journal of Rheumatic Diseases 1401:Arnold RJ, Zhou Y, Wong KS, Sung J (2005). 1279:The Cochrane Database of Systematic Reviews 345:transcutaneous electrical nerve stimulation 145:Quality of Life Index for Atopic Dermatitis 2069:European Archives of Oto-Rhino-Laryngology 1840:|...|intentional=yes}} 6788: 6743: 6667: 6573: 6524: 6175: 6165: 6124: 6114: 5996: 5986: 5945: 5904: 5864: 5827: 5778: 5729: 5667:Journal of Cutaneous Medicine and Surgery 5562: 5293: 5158: 5073: 4945: 4861: 4651: 4531: 4490: 4449: 4416: 4332: 4283: 4234: 4186: 4176: 4057: 4008: 3959: 3719: 3678: 3637: 3612:Ebrahim S, Barer D, Nouri F (June 1986). 3468: 3458: 3301: 3140: 3065: 2858: 2614: 2522: 2512: 2132: 2035: 2025: 1905: 1872: 1699: 1666: 1625: 1584: 1543: 1494: 1418: 1347: 1306: 1249: 1157: 1108: 1059: 1018: 977: 967: 926: 764: 4399:Doward LC, McKenna SP, Meads DM (2003). 3501:The European Journal of Health Economics 2261:International Journal of Nursing Studies 318:attention deficit hyperactivity disorder 4720:International Journal of STD & AIDS 3215:. SAGE Publications. pp. 938–940. 3213:Encyclopedia of Medical Decision Making 1804:Cochrane Database of Systematic Reviews 613: 3789:The Journal of Laryngology and Otology 552:, as well as trials which investigate 518:Pachyonychia Congenita Quality of Life 90:Ankylosing Spondylitis Quality of Life 3708:Nephrology, Dialysis, Transplantation 3579:Social Science & Medicine, Part A 3418:. Mapi Research Trust. Archived from 202:Chronic obstructive pulmonary disease 7: 6458:Scandinavian Journal of Rheumatology 6394:"Psoriasis: management of psoriasis" 6279:International Journal of Dermatology 6103:Drug Design, Development and Therapy 5062:Kidney & Blood Pressure Research 4972:Pharmacoepidemiology and Drug Safety 528:Rheumatoid Arthritis Quality of Life 6209:International Journal of Cardiology 6154:Health and Quality of Life Outcomes 5975:Health and Quality of Life Outcomes 5859:. Springer Science+Business Media. 4165:Health and Quality of Life Outcomes 3447:Health and Quality of Life Outcomes 1718:Archives of Dermatological Research 868:International Journal of Cardiology 578:Psoriatic Arthritis Quality of Life 356:Short Form 36 (SF-36) Health Survey 275:Unidimensional Fatigue Impact Scale 238:United Kingdom Department of Health 212:Quality of Life in Depression Scale 6617:Plastic and Reconstructive Surgery 6326:The British Journal of Dermatology 2652:10.1111/j.1528-1157.1993.tb05912.x 2556:The Journal of Clinical Psychiatry 1761:The British Journal of Dermatology 833:The American Journal of Cardiology 564:Psoriasis Index of Quality of Life 14: 4811:Growth Hormone & IGF Research 4038:American Journal of Public Health 455:Migraine Specific Quality of Life 337:erythropoiesis-stimulating agents 6685:Annals of the Rheumatic Diseases 6554:Annals of the Rheumatic Diseases 6505:Annals of the Rheumatic Diseases 6338:10.1046/j.1365-2133.2003.05492.x 6291:10.1111/j.1365-4632.2005.01941.x 6191: 6012: 5808:Annals of the Rheumatic Diseases 5332:10.1111/j.1468-2982.2007.01472.x 5247:10.1111/j.1468-2982.2007.01367.x 5204:10.1046/j.1526-4610.2000.00086.x 4899:10.1046/j.1365-2265.1998.00634.x 4863:10.1111/j.1524-4733.2009.00689.x 4779:10.1046/j.1365-2265.2000.00899.x 4492:10.1111/j.1524-4733.2008.00424.x 4451:10.1111/j.1524-4733.2008.00450.x 4202: 4001:10.1176/appi.neuropsych.12070175 3901:Arab Journal of Gastroenterology 3870:10.1097/00005650-199206000-00002 3758:10.1111/j.1365-2265.2011.04074.x 3484: 2538: 2369:10.1097/00005650-200210000-00009 2051: 1944:10.1111/j.1756-185X.2010.01580.x 1773:10.1111/j.1365-2133.2012.11113.x 1496:10.1111/j.1468-3083.2006.01383.x 1089:Annals of the Rheumatic Diseases 956:Arthritis Research & Therapy 907:Annals of the Rheumatic Diseases 802:10.1111/j.1525-1403.2010.00321.x 718:10.2165/11599140-000000000-00000 18:patient-reported quality of life 5820:10.1136/annrheumdis-2011-201282 5718:British Journal of Rheumatology 4632:Sexually Transmitted Infections 2462:Journal of Psychiatric Research 2435:Actas Españolas de Psiquiatría 2273:10.1016/j.ijnurstu.2012.07.017 1823:10.1002/14651858.cd010080.pub2 1291:10.1002/14651858.CD001277.pub4 1: 6773:Arthritis Care & Research 6669:10.1016/S1098-3015(10)75273-6 6436:. EU Clinical Trials Register 5731:10.1093/rheumatology/36.8.878 4418:10.1016/S1098-3015(10)61938-9 3209:"Quality of Well-Being Scale" 2725:10.1016/s0920-1211(99)00075-3 2474:10.1016/S0022-3956(02)00060-2 2334:10.1016/S0300-2896(09)72948-5 1975:Social Science & Medicine 1874:10.1016/S1098-3015(10)63408-0 1701:10.1016/S1098-3015(10)62005-0 1668:10.1016/S1098-3015(10)62870-7 1420:10.1016/S1098-3015(10)62872-0 845:10.1016/j.amjcard.2013.02.045 20:surveys used in the field of 6775:. 63 Suppl 11 (11): S413-9. 6629:10.1097/PRS.0b013e3181d4fd89 6221:10.1016/j.ijcard.2010.02.020 5645:. European Medicines Council 5120:10.1016/j.arcmed.2013.10.017 5108:Archives of Medical Research 4593:Journal of Clinical Virology 4358:Journal of Child Health Care 3591:10.1016/0271-7123(81)90005-5 3390:10.1016/0168-8510(96)00822-6 2932:10.3928/01913913-20110517-02 2412:10.1016/0168-8510(92)90005-V 2322:Archivos de Bronconeumologia 2186:10.1097/MAO.0000000000002131 1987:10.1016/0277-9536(94)90463-4 880:10.1016/j.ijcard.2009.09.538 796:(1): 13–8, discussion 18–9. 766:10.1016/0735-1097(94)00397-9 598:Systemic lupus erythematosus 6767:Yazdany J (November 2011). 6745:10.1093/rheumatology/kes370 5947:10.1093/rheumatology/keq194 5780:10.1093/rheumatology/kes296 5643:Eu Clinical Trials Register 5619:. European Medicines Agency 5617:EU Clinical Trials Register 5593:. European Medicines Agency 5591:EU Clinical Trials Register 4272:The Journal of Rheumatology 2860:10.1001/archopht.119.7.1050 2812:10.1016/j.yebeh.2012.04.129 2769:10.1016/j.yebeh.2013.02.014 1907:10.1302/0301-620X.80B1.7859 1242:10.1016/j.aprim.2013.04.005 602:Arthritis Research Campaign 6834: 5406:Multiple Sclerosis Journal 4823:10.1016/j.ghir.2011.07.005 4533:10.1016/j.jval.2011.08.193 4334:10.1016/j.ajog.2013.09.025 3556:10.1016/j.bone.2013.11.002 3312:10.1177/0272989X9701700409 1627:10.1016/j.jval.2011.11.028 1349:10.1016/j.rmed.2009.11.023 457:(MSQoL) was funded by the 80:refractory angina pectoris 6470:10.3109/03009740903468982 6434:ClinicalTrialsRegister.eu 6042:10.1007/s11136-005-3513-4 5857:Current Controlled Trials 5412:(4 Suppl): 55–277. 2012. 4605:10.1016/j.jcv.2008.06.004 4236:10.3109/07853890109002092 4095:10.1161/01.STR.28.11.2155 3952:10.1007/s00520-013-2038-6 3940:Supportive Care in Cancer 3913:10.1016/j.ajg.2013.08.004 3801:10.1017/S0022215106000910 3513:10.1007/s10198-013-0540-x 3178:10.1007/s11136-016-1337-z 3133:10.1007/s40271-013-0036-x 3058:10.1007/s11136-011-0009-2 2968:10.1007/s11136-013-0412-y 2847:Archives of Ophthalmology 2230:10.1016/j.anl.2018.05.008 2174:Otology & Neurotology 2081:10.1007/s00405-016-3915-7 1812:10.1002/14651858.CD010080 1730:10.1007/s00403-010-1082-z 1448:10.1007/s11136-004-4231-z 435:growth hormone deficiency 427:Growth hormone deficiency 333:Nottingham Health Profile 6030:Quality of Life Research 5893:Arthritis and Rheumatism 5551:Arthritis and Rheumatism 5516:10.1177/1352458512463481 5418:10.1177/1352458512459019 5375:10.1177/1352458509106513 5015:Quality of Life Research 4732:10.1258/0956462011923859 4677:Quality of Life Research 4549:Quality of Life Research 4370:10.1177/1367493513496909 3460:10.1186/1477-7525-11-200 3343:Arthritis and Rheumatism 3247:Quality of Life Research 3166:Quality of Life Research 3046:Quality of Life Research 3011:10.1177/1352458509106714 2956:Quality of Life Research 1436:Quality of Life Research 1048:Arthritis and Rheumatism 1007:Arthritis and Rheumatism 379:Johns Hopkins University 343:replacement therapy and 304:disease, amongst others. 120:Asthma Life Impact Scale 34:patient-reported outcome 6697:10.1136/ard.2007.086009 6566:10.1136/ard.2006.063818 6517:10.1136/ard.2003.006296 6167:10.1186/1477-7525-11-31 5680:10.2310/7750.2014.14017 5160:10.1111/1756-185X.12171 4689:10.1023/A:1008904227182 4561:10.1023/A:1008857426633 4118:Intensive Care Medicine 4050:10.2105/AJPH.65.12.1304 3412:"Euroqol EQ-5D (EQ-5D)" 3290:Medical Decision Making 3259:10.1023/A:1018456031659 2800:Epilepsy & Behavior 2757:Epilepsy & Behavior 2113:Clinical Otolaryngology 1586:10.1067/mai.2002.126500 291:https://www.aqol.com.au 234:Diabetes Health Profile 167:(Knee replacement).The 68:spinal cord stimulation 28:, and other scientific 6596:Clinical trial number 5988:10.1186/1477-7525-6-65 5866:10.1186/ISRCTN21216199 4887:Clinical Endocrinology 4767:Clinical Endocrinology 4178:10.1186/1477-7525-1-54 3746:Clinical Endocrinology 2514:10.1186/1471-244X-7-43 2027:10.1186/1471-2431-9-11 1101:10.1136/ard.62.10.1020 685:Clinical trial number 667:Clinical trial number 649:Clinical trial number 542:Pulmonary hypertension 514:Pachyonychia Congenita 86:Ankylosing spondylitis 6256:10.1378/chest.07-2681 5295:10.1093/fampra/cmr112 4285:10.3899/jrheum.130176 3630:10.1136/jech.40.2.166 3221:10.4135/9781412971980 1832:|...}} 1817:(Retracted, see 1545:10.1542/peds.110.1.e2 4947:10.1210/jc.2004-0832 4644:10.1136/sti.75.6.398 2897:10.1167/iovs.10-5645 2607:10.4088/PCC.v03n0103 2568:10.4088/JCP.v67n0510 1336:Respiratory Medicine 524:Rheumatoid arthritis 391:urinary incontinence 364:giardia intestinalis 254:macular degeneration 32:. These surveys are 6368:"Measures Database" 6116:10.2147/DDDT.S19281 6072:"Measures Database" 5451:on November 8, 2013 3090:"Measures Database" 2646:(Suppl. 4): S22-7. 2295:"Measures Database" 1150:10.1136/thx.47.2.76 919:10.1136/ard.62.1.20 574:Psoriatic arthritis 496:University of Leeds 459:Wellcome Foundation 387:knee osteoarthritis 372:Parkinson's disease 113:McMaster University 54:Alzheimer's disease 6604:ClinicalTrials.gov 6372:Galen-Research.com 6076:Galen-Research.com 5504:Multiple Sclerosis 5363:Multiple Sclerosis 5027:10.1007/BF00451725 4223:Annals of Medicine 4130:10.1007/BF01713939 3721:10.1093/ndt/gfr697 3422:on 31 January 2015 3094:Galen-Research.com 2999:Multiple Sclerosis 2299:Galen-Research.com 2218:Auris Nasus Larynx 1380:Galen-Research.com 693:ClinicalTrials.gov 675:ClinicalTrials.gov 657:ClinicalTrials.gov 629:Galen-Research.com 508:hydroxychloroquine 474:Multiple sclerosis 314:overactive bladder 6781:10.1002/acr.20636 5906:10.1002/art.20712 5564:10.1002/art.23714 5075:10.1159/000355717 3585:(3 Pt 1): 221–9. 3355:10.1002/art.20071 3230:978-1-4129-7198-0 3207:Kattan M (2009). 3172:(12): 3209–3219. 2713:Epilepsy Research 2125:10.1111/coa.13275 1230:Atencion Primaria 1195:10.1159/000356336 1020:10.1002/art.22887 706:Drugs & Aging 173:Oxford University 169:Oxford knee score 128:Atopic dermatitis 36:measures, may be 6825: 6803: 6802: 6792: 6764: 6758: 6757: 6747: 6723: 6717: 6716: 6680: 6674: 6673: 6671: 6647: 6641: 6640: 6612: 6606: 6594: 6588: 6587: 6577: 6545: 6539: 6538: 6528: 6496: 6490: 6489: 6452: 6446: 6445: 6443: 6441: 6426: 6420: 6419: 6417: 6415: 6409: 6398: 6390: 6384: 6383: 6381: 6379: 6374:. Galen Research 6364: 6358: 6357: 6317: 6311: 6310: 6274: 6268: 6267: 6239: 6233: 6232: 6203: 6197: 6196: 6195: 6189: 6179: 6169: 6145: 6139: 6138: 6128: 6118: 6094: 6088: 6087: 6085: 6083: 6078:. Galen Research 6068: 6062: 6061: 6024: 6018: 6017: 6016: 6010: 6000: 5990: 5966: 5960: 5959: 5949: 5925: 5919: 5918: 5908: 5884: 5878: 5877: 5875: 5873: 5868: 5848: 5842: 5841: 5831: 5799: 5793: 5792: 5782: 5758: 5752: 5751: 5733: 5709: 5700: 5699: 5661: 5655: 5654: 5652: 5650: 5635: 5629: 5628: 5626: 5624: 5609: 5603: 5602: 5600: 5598: 5583: 5577: 5576: 5566: 5542: 5536: 5535: 5498: 5492: 5491: 5489: 5487: 5467: 5461: 5460: 5458: 5456: 5436: 5430: 5429: 5401: 5395: 5394: 5358: 5352: 5351: 5314: 5308: 5307: 5297: 5273: 5267: 5266: 5230: 5224: 5223: 5187: 5181: 5180: 5162: 5138: 5132: 5131: 5102: 5096: 5095: 5077: 5053: 5047: 5046: 5010: 5004: 5003: 4984:10.1002/pds.1510 4966: 4960: 4959: 4949: 4925: 4919: 4918: 4882: 4876: 4875: 4865: 4841: 4835: 4834: 4805: 4799: 4798: 4761: 4752: 4751: 4715: 4709: 4708: 4672: 4666: 4665: 4655: 4623: 4617: 4616: 4587: 4581: 4580: 4544: 4538: 4537: 4535: 4511: 4505: 4504: 4494: 4470: 4464: 4463: 4453: 4429: 4423: 4422: 4420: 4396: 4390: 4389: 4353: 4347: 4346: 4336: 4312: 4306: 4305: 4287: 4263: 4257: 4256: 4238: 4214: 4208: 4207: 4206: 4200: 4190: 4180: 4156: 4150: 4149: 4113: 4107: 4106: 4078: 4072: 4071: 4061: 4029: 4023: 4022: 4012: 3980: 3974: 3973: 3963: 3931: 3925: 3924: 3896: 3890: 3889: 3853: 3847: 3846: 3844: 3842: 3827: 3821: 3820: 3784: 3778: 3777: 3740: 3734: 3733: 3723: 3699: 3693: 3692: 3682: 3658: 3652: 3651: 3641: 3609: 3603: 3602: 3574: 3568: 3567: 3539: 3533: 3532: 3496: 3490: 3489: 3488: 3482: 3472: 3462: 3438: 3432: 3431: 3429: 3427: 3408: 3402: 3401: 3373: 3367: 3366: 3338: 3332: 3331: 3305: 3303:10.1.1.1004.6037 3285: 3279: 3278: 3241: 3235: 3234: 3204: 3198: 3197: 3161: 3155: 3154: 3144: 3112: 3106: 3105: 3103: 3101: 3096:. Galen Research 3086: 3080: 3079: 3069: 3037: 3031: 3030: 2994: 2988: 2987: 2950: 2944: 2943: 2915: 2909: 2908: 2879: 2873: 2872: 2862: 2838: 2832: 2831: 2795: 2789: 2788: 2751: 2745: 2744: 2704: 2698: 2697: 2695: 2693: 2678: 2672: 2671: 2635: 2629: 2628: 2618: 2586: 2580: 2579: 2550: 2544: 2543: 2542: 2536: 2526: 2516: 2492: 2486: 2485: 2457: 2451: 2450: 2430: 2424: 2423: 2395: 2389: 2388: 2352: 2346: 2345: 2328:(Suppl 5): 2–6. 2317: 2311: 2310: 2308: 2306: 2301:. Galen Research 2291: 2285: 2284: 2256: 2250: 2249: 2212: 2206: 2205: 2171: 2161: 2155: 2154: 2136: 2107: 2101: 2100: 2063: 2057: 2056: 2055: 2049: 2039: 2029: 2005: 1999: 1998: 1970: 1964: 1963: 1926: 1920: 1919: 1909: 1885: 1879: 1878: 1876: 1852: 1846: 1845: 1843: 1841: 1833: 1815: 1799: 1793: 1792: 1756: 1750: 1749: 1712: 1706: 1705: 1703: 1679: 1673: 1672: 1670: 1646: 1640: 1639: 1629: 1605: 1599: 1598: 1588: 1564: 1558: 1557: 1547: 1523: 1517: 1516: 1498: 1474: 1468: 1467: 1431: 1425: 1424: 1422: 1398: 1392: 1391: 1389: 1387: 1382:. Galen Research 1377: 1368: 1362: 1361: 1351: 1327: 1321: 1320: 1310: 1270: 1264: 1263: 1253: 1221: 1215: 1214: 1178: 1172: 1171: 1161: 1129: 1123: 1122: 1112: 1080: 1074: 1073: 1063: 1039: 1033: 1032: 1022: 998: 992: 991: 981: 971: 947: 941: 940: 930: 898: 892: 891: 863: 857: 856: 828: 822: 821: 785: 779: 778: 768: 744: 738: 737: 701: 695: 683: 677: 665: 659: 647: 641: 640: 638: 636: 631:. Galen Research 626: 618: 360:RAND corporation 192:with or without 16:This page lists 6833: 6832: 6828: 6827: 6826: 6824: 6823: 6822: 6808: 6807: 6806: 6766: 6765: 6761: 6725: 6724: 6720: 6682: 6681: 6677: 6656:Value in Health 6649: 6648: 6644: 6614: 6613: 6609: 6595: 6591: 6547: 6546: 6542: 6498: 6497: 6493: 6454: 6453: 6449: 6439: 6437: 6428: 6427: 6423: 6413: 6411: 6407: 6396: 6392: 6391: 6387: 6377: 6375: 6366: 6365: 6361: 6319: 6318: 6314: 6276: 6275: 6271: 6241: 6240: 6236: 6205: 6204: 6200: 6190: 6147: 6146: 6142: 6096: 6095: 6091: 6081: 6079: 6070: 6069: 6065: 6026: 6025: 6021: 6011: 5968: 5967: 5963: 5927: 5926: 5922: 5886: 5885: 5881: 5871: 5869: 5850: 5849: 5845: 5801: 5800: 5796: 5760: 5759: 5755: 5711: 5710: 5703: 5663: 5662: 5658: 5648: 5646: 5637: 5636: 5632: 5622: 5620: 5611: 5610: 5606: 5596: 5594: 5585: 5584: 5580: 5544: 5543: 5539: 5500: 5499: 5495: 5485: 5483: 5469: 5468: 5464: 5454: 5452: 5438: 5437: 5433: 5403: 5402: 5398: 5369:(9): 1092–102. 5360: 5359: 5355: 5316: 5315: 5311: 5282:Family Practice 5275: 5274: 5270: 5232: 5231: 5227: 5189: 5188: 5184: 5140: 5139: 5135: 5104: 5103: 5099: 5068:(4–5): 464–74. 5055: 5054: 5050: 5012: 5011: 5007: 4968: 4967: 4963: 4927: 4926: 4922: 4884: 4883: 4879: 4850:Value in Health 4843: 4842: 4838: 4807: 4806: 4802: 4763: 4762: 4755: 4717: 4716: 4712: 4674: 4673: 4669: 4625: 4624: 4620: 4589: 4588: 4584: 4546: 4545: 4541: 4520:Value in Health 4513: 4512: 4508: 4479:Value in Health 4472: 4471: 4467: 4438:Value in Health 4431: 4430: 4426: 4405:Value in Health 4398: 4397: 4393: 4355: 4354: 4350: 4314: 4313: 4309: 4278:(12): 2075–82. 4265: 4264: 4260: 4216: 4215: 4211: 4201: 4158: 4157: 4153: 4115: 4114: 4110: 4089:(11): 2155–61. 4080: 4079: 4075: 4044:(12): 1304–10. 4031: 4030: 4026: 3982: 3981: 3977: 3933: 3932: 3928: 3898: 3897: 3893: 3855: 3854: 3850: 3840: 3838: 3829: 3828: 3824: 3786: 3785: 3781: 3742: 3741: 3737: 3701: 3700: 3696: 3660: 3659: 3655: 3611: 3610: 3606: 3576: 3575: 3571: 3541: 3540: 3536: 3498: 3497: 3493: 3483: 3440: 3439: 3435: 3425: 3423: 3410: 3409: 3405: 3375: 3374: 3370: 3340: 3339: 3335: 3287: 3286: 3282: 3243: 3242: 3238: 3231: 3206: 3205: 3201: 3163: 3162: 3158: 3114: 3113: 3109: 3099: 3097: 3088: 3087: 3083: 3039: 3038: 3034: 3005:(10): 1228–38. 2996: 2995: 2991: 2952: 2951: 2947: 2917: 2916: 2912: 2881: 2880: 2876: 2840: 2839: 2835: 2797: 2796: 2792: 2753: 2752: 2748: 2706: 2705: 2701: 2691: 2689: 2680: 2679: 2675: 2637: 2636: 2632: 2588: 2587: 2583: 2552: 2551: 2547: 2537: 2494: 2493: 2489: 2459: 2458: 2454: 2432: 2431: 2427: 2397: 2396: 2392: 2354: 2353: 2349: 2319: 2318: 2314: 2304: 2302: 2293: 2292: 2288: 2258: 2257: 2253: 2214: 2213: 2209: 2169: 2163: 2162: 2158: 2109: 2108: 2104: 2075:(10): 3073–81. 2065: 2064: 2060: 2050: 2007: 2006: 2002: 1972: 1971: 1967: 1928: 1927: 1923: 1887: 1886: 1882: 1861:Value in Health 1854: 1853: 1849: 1835: 1827: 1825: 1816: 1801: 1800: 1796: 1758: 1757: 1753: 1714: 1713: 1709: 1688:Value in Health 1681: 1680: 1676: 1655:Value in Health 1648: 1647: 1643: 1614:Value in Health 1607: 1606: 1602: 1566: 1565: 1561: 1525: 1524: 1520: 1476: 1475: 1471: 1433: 1432: 1428: 1407:Value in Health 1400: 1399: 1395: 1385: 1383: 1375: 1370: 1369: 1365: 1329: 1328: 1324: 1285:(3): CD001277. 1272: 1271: 1267: 1223: 1222: 1218: 1180: 1179: 1175: 1131: 1130: 1126: 1082: 1081: 1077: 1041: 1040: 1036: 1000: 999: 995: 949: 948: 944: 900: 899: 895: 865: 864: 860: 830: 829: 825: 790:Neuromodulation 787: 786: 782: 746: 745: 741: 703: 702: 698: 684: 680: 666: 662: 648: 644: 634: 632: 624: 620: 619: 615: 611: 302:musculoskeletal 153:corticosteroids 50: 26:pharmaceuticals 12: 11: 5: 6831: 6829: 6821: 6820: 6810: 6809: 6805: 6804: 6759: 6718: 6691:(2): 196–200. 6675: 6642: 6623:(5): 1439–49. 6607: 6589: 6540: 6491: 6447: 6430:"CAEB071C2201" 6421: 6385: 6359: 6312: 6269: 6250:(2): 229–236. 6234: 6198: 6140: 6089: 6063: 6019: 5961: 5940:(10): 1971–4. 5920: 5879: 5843: 5794: 5753: 5701: 5656: 5630: 5604: 5578: 5537: 5493: 5462: 5431: 5396: 5353: 5309: 5268: 5225: 5182: 5133: 5097: 5048: 5005: 4961: 4920: 4877: 4856:(4): 495–500. 4836: 4800: 4753: 4710: 4667: 4638:(6): 398–402. 4618: 4582: 4539: 4506: 4465: 4444:(2): 397–400. 4424: 4411:(6): 760–761. 4391: 4348: 4327:(1): 85.e1–6. 4307: 4258: 4209: 4151: 4108: 4073: 4024: 3975: 3926: 3891: 3848: 3822: 3779: 3735: 3714:(6): 2418–25. 3694: 3673:(273): 185–8. 3653: 3604: 3569: 3534: 3491: 3433: 3403: 3368: 3333: 3280: 3236: 3229: 3199: 3156: 3107: 3081: 3032: 2989: 2962:(10): 2801–8. 2945: 2910: 2874: 2833: 2790: 2746: 2699: 2673: 2630: 2581: 2545: 2501:BMC Psychiatry 2487: 2452: 2425: 2390: 2363:(10): 918–28. 2347: 2324:(in Spanish). 2312: 2286: 2267:(5): 688–707. 2251: 2207: 2180:(3): 351–358. 2156: 2119:(3): 254–262. 2102: 2058: 2014:BMC Pediatrics 2000: 1965: 1921: 1880: 1847: 1794: 1767:(5): 1025–31. 1751: 1707: 1694:(6): 787–788. 1674: 1661:(3): 331–332. 1641: 1600: 1559: 1538:(1 Pt 1): e2. 1518: 1469: 1426: 1393: 1363: 1322: 1265: 1216: 1173: 1124: 1095:(10): 1020–1. 1075: 1034: 993: 969:10.1186/ar2790 942: 893: 858: 823: 780: 739: 712:(3): 167–179. 696: 678: 660: 642: 612: 610: 607: 606: 605: 595: 589: 571: 557: 539: 521: 511: 492:Osteoarthritis 489: 471: 448: 445:Kidney disease 442: 423: 422: 415: 407: 403: 402: 399:Genital herpes 395: 394: 382: 375: 370:survivors and 352: 341:glucocorticoid 329: 305: 294: 285: 284: 281:General Health 278: 268: 247: 241: 227: 205: 198: 197: 182: 176: 161: 160: 141: 132: 131: 124: 123: 116: 108: 107: 101: 83: 61: 49: 46: 38:questionnaires 13: 10: 9: 6: 4: 3: 2: 6830: 6819: 6818:Medical lists 6816: 6815: 6813: 6800: 6796: 6791: 6786: 6782: 6778: 6774: 6770: 6763: 6760: 6755: 6751: 6746: 6741: 6738:(4): 684–96. 6737: 6733: 6729: 6722: 6719: 6714: 6710: 6706: 6702: 6698: 6694: 6690: 6686: 6679: 6676: 6670: 6665: 6661: 6657: 6653: 6646: 6643: 6638: 6634: 6630: 6626: 6622: 6618: 6611: 6608: 6605: 6601: 6600: 6593: 6590: 6585: 6581: 6576: 6571: 6567: 6563: 6560:(6): 778–81. 6559: 6555: 6551: 6544: 6541: 6536: 6532: 6527: 6522: 6518: 6514: 6510: 6506: 6502: 6495: 6492: 6487: 6483: 6479: 6475: 6471: 6467: 6463: 6459: 6451: 6448: 6435: 6431: 6425: 6422: 6410:on 2013-11-13 6406: 6402: 6395: 6389: 6386: 6373: 6369: 6363: 6360: 6355: 6351: 6347: 6343: 6339: 6335: 6332:(2): 323–31. 6331: 6327: 6323: 6316: 6313: 6308: 6304: 6300: 6296: 6292: 6288: 6284: 6280: 6273: 6270: 6265: 6261: 6257: 6253: 6249: 6245: 6238: 6235: 6230: 6226: 6222: 6218: 6214: 6210: 6202: 6199: 6194: 6187: 6183: 6178: 6173: 6168: 6163: 6159: 6155: 6151: 6144: 6141: 6136: 6132: 6127: 6122: 6117: 6112: 6108: 6104: 6100: 6093: 6090: 6077: 6073: 6067: 6064: 6059: 6055: 6051: 6047: 6043: 6039: 6036:(1): 103–15. 6035: 6031: 6023: 6020: 6015: 6008: 6004: 5999: 5994: 5989: 5984: 5980: 5976: 5972: 5965: 5962: 5957: 5953: 5948: 5943: 5939: 5935: 5931: 5924: 5921: 5916: 5912: 5907: 5902: 5898: 5894: 5890: 5883: 5880: 5867: 5862: 5858: 5854: 5851:Fahy, Sarah. 5847: 5844: 5839: 5835: 5830: 5825: 5821: 5817: 5813: 5809: 5805: 5798: 5795: 5790: 5786: 5781: 5776: 5772: 5768: 5764: 5757: 5754: 5749: 5745: 5741: 5737: 5732: 5727: 5724:(8): 878–83. 5723: 5719: 5715: 5708: 5706: 5702: 5697: 5693: 5689: 5685: 5681: 5677: 5673: 5669: 5668: 5660: 5657: 5644: 5640: 5634: 5631: 5618: 5614: 5608: 5605: 5592: 5588: 5582: 5579: 5574: 5570: 5565: 5560: 5556: 5552: 5548: 5541: 5538: 5533: 5529: 5525: 5521: 5517: 5513: 5509: 5505: 5497: 5494: 5481: 5477: 5473: 5466: 5463: 5450: 5446: 5442: 5435: 5432: 5427: 5423: 5419: 5415: 5411: 5407: 5400: 5397: 5392: 5388: 5384: 5380: 5376: 5372: 5368: 5364: 5357: 5354: 5349: 5345: 5341: 5337: 5333: 5329: 5326:(2): 127–38. 5325: 5321: 5313: 5310: 5305: 5301: 5296: 5291: 5287: 5283: 5279: 5272: 5269: 5264: 5260: 5256: 5252: 5248: 5244: 5240: 5236: 5229: 5226: 5221: 5217: 5213: 5209: 5205: 5201: 5198:(7): 550–60. 5197: 5193: 5186: 5183: 5178: 5174: 5170: 5166: 5161: 5156: 5153:(2): 159–66. 5152: 5148: 5144: 5137: 5134: 5129: 5125: 5121: 5117: 5114:(8): 655–61. 5113: 5109: 5101: 5098: 5093: 5089: 5085: 5081: 5076: 5071: 5067: 5063: 5059: 5052: 5049: 5044: 5040: 5036: 5032: 5028: 5024: 5021:(5): 329–38. 5020: 5016: 5009: 5006: 5001: 4997: 4993: 4989: 4985: 4981: 4978:(1): 90–102. 4977: 4973: 4965: 4962: 4957: 4953: 4948: 4943: 4940:(3): 1542–9. 4939: 4935: 4931: 4924: 4921: 4916: 4912: 4908: 4904: 4900: 4896: 4893:(6): 765–71. 4892: 4888: 4881: 4878: 4873: 4869: 4864: 4859: 4855: 4851: 4847: 4840: 4837: 4832: 4828: 4824: 4820: 4816: 4812: 4804: 4801: 4796: 4792: 4788: 4784: 4780: 4776: 4773:(2): 143–52. 4772: 4768: 4760: 4758: 4754: 4749: 4745: 4741: 4737: 4733: 4729: 4726:(10): 640–5. 4725: 4721: 4714: 4711: 4706: 4702: 4698: 4694: 4690: 4686: 4683:(4): 365–71. 4682: 4678: 4671: 4668: 4663: 4659: 4654: 4649: 4645: 4641: 4637: 4633: 4629: 4622: 4619: 4614: 4610: 4606: 4602: 4598: 4594: 4586: 4583: 4578: 4574: 4570: 4566: 4562: 4558: 4555:(2): 143–53. 4554: 4550: 4543: 4540: 4534: 4529: 4525: 4521: 4517: 4510: 4507: 4502: 4498: 4493: 4488: 4485:(1): 139–45. 4484: 4480: 4476: 4469: 4466: 4461: 4457: 4452: 4447: 4443: 4439: 4435: 4428: 4425: 4419: 4414: 4410: 4406: 4402: 4395: 4392: 4387: 4383: 4379: 4375: 4371: 4367: 4363: 4359: 4352: 4349: 4344: 4340: 4335: 4330: 4326: 4322: 4318: 4311: 4308: 4303: 4299: 4295: 4291: 4286: 4281: 4277: 4273: 4269: 4262: 4259: 4254: 4250: 4246: 4242: 4237: 4232: 4229:(5): 375–84. 4228: 4224: 4220: 4213: 4210: 4205: 4198: 4194: 4189: 4184: 4179: 4174: 4170: 4166: 4162: 4155: 4152: 4147: 4143: 4139: 4135: 4131: 4127: 4123: 4119: 4112: 4109: 4104: 4100: 4096: 4092: 4088: 4084: 4077: 4074: 4069: 4065: 4060: 4055: 4051: 4047: 4043: 4039: 4035: 4028: 4025: 4020: 4016: 4011: 4006: 4002: 3998: 3995:(4): 319–26. 3994: 3990: 3986: 3979: 3976: 3971: 3967: 3962: 3957: 3953: 3949: 3945: 3941: 3937: 3930: 3927: 3922: 3918: 3914: 3910: 3906: 3902: 3895: 3892: 3887: 3883: 3879: 3875: 3871: 3867: 3864:(6): 473–83. 3863: 3859: 3852: 3849: 3836: 3832: 3826: 3823: 3818: 3814: 3810: 3806: 3802: 3798: 3794: 3790: 3783: 3780: 3775: 3771: 3767: 3763: 3759: 3755: 3752:(4): 505–13. 3751: 3747: 3739: 3736: 3731: 3727: 3722: 3717: 3713: 3709: 3705: 3698: 3695: 3690: 3686: 3681: 3676: 3672: 3668: 3664: 3657: 3654: 3649: 3645: 3640: 3635: 3631: 3627: 3623: 3619: 3615: 3608: 3605: 3600: 3596: 3592: 3588: 3584: 3580: 3573: 3570: 3565: 3561: 3557: 3553: 3549: 3545: 3538: 3535: 3530: 3526: 3522: 3518: 3514: 3510: 3507:(9): 967–77. 3506: 3502: 3495: 3492: 3487: 3480: 3476: 3471: 3466: 3461: 3456: 3452: 3448: 3444: 3437: 3434: 3421: 3417: 3413: 3407: 3404: 3399: 3395: 3391: 3387: 3383: 3379: 3378:Health Policy 3372: 3369: 3364: 3360: 3356: 3352: 3348: 3344: 3337: 3334: 3329: 3325: 3321: 3317: 3313: 3309: 3304: 3299: 3296:(4): 439–46. 3295: 3291: 3284: 3281: 3276: 3272: 3268: 3264: 3260: 3256: 3253:(6): 507–14. 3252: 3248: 3240: 3237: 3232: 3226: 3222: 3218: 3214: 3210: 3203: 3200: 3195: 3191: 3187: 3183: 3179: 3175: 3171: 3167: 3160: 3157: 3152: 3148: 3143: 3138: 3134: 3130: 3126: 3122: 3118: 3111: 3108: 3095: 3091: 3085: 3082: 3077: 3073: 3068: 3063: 3059: 3055: 3052:(6): 925–44. 3051: 3047: 3043: 3036: 3033: 3028: 3024: 3020: 3016: 3012: 3008: 3004: 3000: 2993: 2990: 2985: 2981: 2977: 2973: 2969: 2965: 2961: 2957: 2949: 2946: 2941: 2937: 2933: 2929: 2925: 2921: 2914: 2911: 2906: 2902: 2898: 2894: 2891:(6): 3354–9. 2890: 2886: 2878: 2875: 2870: 2866: 2861: 2856: 2853:(7): 1050–8. 2852: 2848: 2844: 2837: 2834: 2829: 2825: 2821: 2817: 2813: 2809: 2806:(3): 345–51. 2805: 2801: 2794: 2791: 2786: 2782: 2778: 2774: 2770: 2766: 2762: 2758: 2750: 2747: 2742: 2738: 2734: 2730: 2726: 2722: 2718: 2714: 2710: 2703: 2700: 2688:. RAND Health 2687: 2683: 2677: 2674: 2669: 2665: 2661: 2657: 2653: 2649: 2645: 2641: 2634: 2631: 2626: 2622: 2617: 2612: 2608: 2604: 2600: 2596: 2592: 2585: 2582: 2577: 2573: 2569: 2565: 2562:(5): 761–70. 2561: 2557: 2549: 2546: 2541: 2534: 2530: 2525: 2520: 2515: 2510: 2506: 2502: 2498: 2491: 2488: 2483: 2479: 2475: 2471: 2468:(6): 383–90. 2467: 2463: 2456: 2453: 2448: 2444: 2440: 2436: 2429: 2426: 2421: 2417: 2413: 2409: 2406:(3): 321–30. 2405: 2401: 2400:Health Policy 2394: 2391: 2386: 2382: 2378: 2374: 2370: 2366: 2362: 2358: 2351: 2348: 2343: 2339: 2335: 2331: 2327: 2323: 2316: 2313: 2300: 2296: 2290: 2287: 2282: 2278: 2274: 2270: 2266: 2262: 2255: 2252: 2247: 2243: 2239: 2235: 2231: 2227: 2223: 2219: 2211: 2208: 2203: 2199: 2195: 2191: 2187: 2183: 2179: 2175: 2168: 2160: 2157: 2152: 2148: 2144: 2140: 2135: 2130: 2126: 2122: 2118: 2114: 2106: 2103: 2098: 2094: 2090: 2086: 2082: 2078: 2074: 2070: 2062: 2059: 2054: 2047: 2043: 2038: 2033: 2028: 2023: 2019: 2015: 2011: 2004: 2001: 1996: 1992: 1988: 1984: 1981:(5): 725–31. 1980: 1976: 1969: 1966: 1961: 1957: 1953: 1949: 1945: 1941: 1938:(2): 206–10. 1937: 1933: 1925: 1922: 1917: 1913: 1908: 1903: 1899: 1895: 1891: 1884: 1881: 1875: 1870: 1866: 1862: 1858: 1851: 1848: 1839: 1831: 1824: 1820: 1813: 1809: 1805: 1798: 1795: 1790: 1786: 1782: 1778: 1774: 1770: 1766: 1762: 1755: 1752: 1747: 1743: 1739: 1735: 1731: 1727: 1723: 1719: 1711: 1708: 1702: 1697: 1693: 1689: 1685: 1678: 1675: 1669: 1664: 1660: 1656: 1652: 1645: 1642: 1637: 1633: 1628: 1623: 1620:(2): 312–22. 1619: 1615: 1611: 1604: 1601: 1596: 1592: 1587: 1582: 1579:(2): 277–84. 1578: 1574: 1570: 1563: 1560: 1555: 1551: 1546: 1541: 1537: 1533: 1529: 1522: 1519: 1514: 1510: 1506: 1502: 1497: 1492: 1489:(3): 248–54. 1488: 1484: 1480: 1473: 1470: 1465: 1461: 1457: 1453: 1449: 1445: 1442:(1): 231–41. 1441: 1437: 1430: 1427: 1421: 1416: 1412: 1408: 1404: 1397: 1394: 1381: 1374: 1371:Crawford SR. 1367: 1364: 1359: 1355: 1350: 1345: 1342:(5): 633–43. 1341: 1337: 1333: 1326: 1323: 1318: 1314: 1309: 1304: 1300: 1296: 1292: 1288: 1284: 1280: 1276: 1269: 1266: 1261: 1257: 1252: 1247: 1243: 1239: 1236:(3): 117–39. 1235: 1231: 1227: 1220: 1217: 1212: 1208: 1204: 1200: 1196: 1192: 1188: 1184: 1177: 1174: 1169: 1165: 1160: 1155: 1151: 1147: 1143: 1139: 1135: 1128: 1125: 1120: 1116: 1111: 1106: 1102: 1098: 1094: 1090: 1086: 1079: 1076: 1071: 1067: 1062: 1057: 1054:(9): 2112–7. 1053: 1049: 1045: 1038: 1035: 1030: 1026: 1021: 1016: 1013:(6): 1050–7. 1012: 1008: 1004: 997: 994: 989: 985: 980: 975: 970: 965: 961: 957: 953: 946: 943: 938: 934: 929: 924: 920: 916: 912: 908: 904: 897: 894: 889: 885: 881: 877: 874:(3): 377–82. 873: 869: 862: 859: 854: 850: 846: 842: 838: 834: 827: 824: 819: 815: 811: 807: 803: 799: 795: 791: 784: 781: 776: 772: 767: 762: 759:(2): 333–41. 758: 754: 750: 743: 740: 735: 731: 727: 723: 719: 715: 711: 707: 700: 697: 694: 690: 689: 682: 679: 676: 672: 671: 664: 661: 658: 654: 653: 646: 643: 630: 623: 617: 614: 608: 603: 599: 596: 593: 590: 587: 583: 579: 575: 572: 569: 565: 561: 558: 555: 551: 547: 543: 540: 537: 533: 529: 525: 522: 519: 515: 512: 509: 505: 501: 497: 493: 490: 487: 483: 479: 475: 472: 469: 465: 460: 456: 452: 449: 446: 443: 440: 436: 432: 428: 425: 424: 420: 416: 413: 408: 405: 404: 400: 397: 396: 392: 388: 383: 380: 376: 373: 369: 368:breast cancer 365: 361: 357: 353: 350: 346: 342: 338: 334: 330: 327: 323: 319: 315: 310: 306: 303: 300:patients and 299: 295: 292: 287: 286: 282: 279: 276: 272: 269: 266: 262: 259: 255: 251: 248: 245: 242: 239: 235: 231: 228: 225: 221: 217: 213: 209: 206: 203: 200: 199: 195: 194:Cholesteatoma 191: 187: 183: 180: 177: 174: 170: 166: 163: 162: 158: 154: 150: 149:questionnaire 146: 142: 139: 134: 133: 129: 126: 125: 121: 117: 114: 110: 109: 105: 102: 99: 95: 91: 87: 84: 81: 77: 73: 69: 65: 62: 59: 58:rosiglitazone 55: 52: 51: 47: 45: 43: 39: 35: 31: 27: 23: 19: 6772: 6762: 6735: 6732:Rheumatology 6731: 6721: 6688: 6684: 6678: 6659: 6655: 6645: 6620: 6616: 6610: 6597: 6592: 6557: 6553: 6543: 6511:(2): 162–9. 6508: 6504: 6494: 6464:(4): 303–9. 6461: 6457: 6450: 6438:. Retrieved 6433: 6424: 6412:. Retrieved 6405:the original 6400: 6388: 6376:. Retrieved 6371: 6362: 6329: 6325: 6322:Griffiths CE 6315: 6285:(6): 462–9. 6282: 6278: 6272: 6247: 6243: 6237: 6215:(3): 372–6. 6212: 6208: 6201: 6157: 6153: 6143: 6106: 6102: 6092: 6080:. Retrieved 6075: 6066: 6033: 6029: 6022: 5978: 5974: 5964: 5937: 5934:Rheumatology 5933: 5923: 5899:(1): 27–35. 5896: 5892: 5882: 5870:. Retrieved 5856: 5846: 5814:(1): 43–50. 5811: 5807: 5797: 5773:(3): 460–4. 5770: 5767:Rheumatology 5766: 5756: 5721: 5717: 5674:(1): 57–65. 5671: 5665: 5659: 5647:. Retrieved 5642: 5633: 5621:. Retrieved 5616: 5607: 5595:. Retrieved 5590: 5581: 5557:(6): 841–8. 5554: 5550: 5540: 5510:(5): 631–8. 5507: 5503: 5496: 5484:. Retrieved 5479: 5475: 5465: 5453:. Retrieved 5449:the original 5444: 5434: 5409: 5405: 5404:"Poster I". 5399: 5366: 5362: 5356: 5323: 5319: 5312: 5288:(4): 370–5. 5285: 5281: 5271: 5241:(8): 920–8. 5238: 5234: 5228: 5195: 5191: 5185: 5150: 5146: 5136: 5111: 5107: 5100: 5065: 5061: 5051: 5018: 5014: 5008: 4975: 4971: 4964: 4937: 4933: 4923: 4890: 4886: 4880: 4853: 4849: 4839: 4817:(5): 272–8. 4814: 4810: 4803: 4770: 4766: 4723: 4719: 4713: 4680: 4676: 4670: 4635: 4631: 4621: 4599:(2): 190–5. 4596: 4592: 4585: 4552: 4548: 4542: 4523: 4519: 4509: 4482: 4478: 4468: 4441: 4437: 4427: 4408: 4404: 4394: 4364:(1): 53–62. 4361: 4357: 4351: 4324: 4320: 4310: 4275: 4271: 4261: 4226: 4222: 4212: 4168: 4164: 4154: 4124:(5): 285–8. 4121: 4117: 4111: 4086: 4082: 4076: 4041: 4037: 4027: 3992: 3988: 3978: 3946:(4): 911–7. 3943: 3939: 3929: 3907:(3): 126–9. 3904: 3900: 3894: 3861: 3858:Medical Care 3857: 3851: 3839:. Retrieved 3834: 3825: 3795:(6): 442–5. 3792: 3788: 3782: 3749: 3745: 3738: 3711: 3707: 3697: 3670: 3666: 3656: 3624:(2): 166–9. 3621: 3617: 3607: 3582: 3578: 3572: 3547: 3543: 3537: 3504: 3500: 3494: 3450: 3446: 3436: 3424:. Retrieved 3420:the original 3416:PROQOLID.org 3415: 3406: 3384:(1): 53–72. 3381: 3377: 3371: 3349:(1): 28–33. 3346: 3342: 3336: 3293: 3289: 3283: 3250: 3246: 3239: 3212: 3202: 3169: 3165: 3159: 3127:(1): 85–96. 3124: 3120: 3110: 3098:. Retrieved 3093: 3084: 3049: 3045: 3035: 3002: 2998: 2992: 2959: 2955: 2948: 2926:(1): 26–31. 2923: 2919: 2913: 2888: 2884: 2877: 2850: 2846: 2836: 2803: 2799: 2793: 2763:(2): 310–4. 2760: 2756: 2749: 2719:(1): 67–74. 2716: 2712: 2702: 2690:. Retrieved 2685: 2676: 2643: 2639: 2633: 2601:(1): 10–16. 2598: 2594: 2584: 2559: 2555: 2548: 2504: 2500: 2490: 2465: 2461: 2455: 2441:(6): 331–8. 2438: 2434: 2428: 2403: 2399: 2393: 2360: 2357:Medical Care 2356: 2350: 2325: 2321: 2315: 2303:. Retrieved 2298: 2289: 2264: 2260: 2254: 2224:(1): 18–23. 2221: 2217: 2210: 2177: 2173: 2159: 2134:11343/285278 2116: 2112: 2105: 2072: 2068: 2061: 2017: 2013: 2003: 1978: 1974: 1968: 1935: 1931: 1924: 1897: 1893: 1883: 1864: 1860: 1850: 1836:{{ 1828:{{ 1803: 1797: 1764: 1760: 1754: 1724:(1): 57–63. 1721: 1717: 1710: 1691: 1687: 1677: 1658: 1654: 1644: 1617: 1613: 1603: 1576: 1572: 1562: 1535: 1531: 1521: 1486: 1482: 1472: 1439: 1435: 1429: 1410: 1406: 1396: 1384:. Retrieved 1379: 1366: 1339: 1335: 1325: 1282: 1278: 1268: 1233: 1229: 1219: 1189:(1): 36–42. 1186: 1182: 1176: 1144:(2): 76–83. 1141: 1137: 1127: 1092: 1088: 1078: 1051: 1047: 1037: 1010: 1006: 996: 959: 955: 945: 910: 906: 896: 871: 867: 861: 836: 832: 826: 793: 789: 783: 756: 752: 742: 709: 705: 699: 686: 681: 668: 663: 650: 645: 633:. Retrieved 628: 616: 550:treprostinil 504:methotrexate 500:prednisolone 486:rivastigmine 326:osteoporosis 190:Otitis media 186:Otitis media 165:Arthroplasty 157:pimecrolimus 138:pimecrolimus 17: 15: 6662:(7): A459. 6599:NCT00427362 6440:13 November 6414:13 November 6401:NICE.org.uk 6378:13 November 5649:20 November 5623:20 November 5597:20 November 5320:Cephalalgia 5235:Cephalalgia 4526:(7): A266. 3841:20 November 3426:20 November 3121:The Patient 3100:20 November 2692:27 November 1900:(1): 63–9. 1867:(6): A268. 962:(4): R124. 913:(1): 20–6. 839:(1): 8–13. 688:NCT00348140 670:NCT00348309 652:NCT00428090 635:11 November 532:tocilizumab 412:famciclovir 250:Eye disease 216:venlafaxine 5455:October 9, 3550:: 105–13. 3453:(1): 200. 2305:11 October 1532:Pediatrics 1413:(3): 332. 1386:14 October 609:References 586:adalimumab 582:infliximab 554:sildenafil 536:infliximab 482:fingolimod 468:topiramate 441:in the UK. 258:congenital 220:duloxetine 208:Depression 179:Chickenpox 98:etanercept 94:adalimumab 76:ranolazine 72:ivabradine 6109:: 19–28. 6082:2 October 5872:2 October 5696:221801367 5486:9 October 5476:Neurology 5426:208625075 5092:207708239 3774:205286522 3298:CiteSeerX 2640:Epilepsia 1838:retracted 1830:retracted 1299:1469-493X 734:207301505 560:Psoriasis 322:denosumab 261:cataracts 224:bupropion 6812:Category 6799:22588761 6754:23264550 6713:23886698 6705:18385276 6637:20440163 6584:17185324 6535:14722205 6486:26425942 6478:20166848 6354:26091210 6346:12932239 6307:22163460 6299:15941432 6264:18263674 6229:20304507 6186:23496856 6135:22291467 6058:23830883 6050:16411035 6007:18718016 5956:20595536 5915:15641102 5838:22562983 5789:23118412 5748:20190839 5688:25775665 5573:18512719 5524:23069874 5383:19556315 5348:44246726 5340:18197883 5304:22113647 5255:17645757 5220:23808987 5212:10940093 5192:Headache 5177:27610428 5169:24176031 5128:24211750 5084:24247643 5043:41098376 5000:31206757 4992:17957812 4956:15613427 4915:31044474 4907:10209564 4872:20102556 4831:21865066 4795:11256536 4787:10671940 4748:32358251 4740:11564330 4705:24573908 4697:10472169 4662:10754944 4613:18621575 4577:19058639 4501:18647252 4460:18783390 4386:23422052 4378:23939724 4343:24055585 4302:35129983 4294:24187098 4253:37589566 4245:11491197 4197:14613568 4019:24247858 3970:24249424 3921:24206742 3886:44458175 3835:RAND.org 3817:43430574 3809:16556347 3766:21521342 3730:22187314 3564:24231131 3529:20429564 3521:24233919 3479:24246044 3398:10158943 3363:14872452 3328:22869619 3186:27344318 3151:24271592 3076:22012025 3027:23273125 3019:19556314 2976:23645458 2940:21598855 2905:21282568 2869:11448327 2828:27975316 2820:22658433 2777:23523814 2741:12205701 2733:10604607 2686:RAND.org 2668:33216251 2625:15014623 2576:16841626 2533:17725843 2482:12393307 2447:14639509 2420:10122731 2385:25950087 2377:12395025 2342:20116755 2281:22921317 2246:46949869 2238:29871811 2202:73436408 2194:30741898 2151:58610511 2143:30588758 2097:10107433 2089:26869474 2046:19200366 1952:21518321 1789:11139439 1781:22709422 1746:20817434 1738:20842368 1636:22433763 1595:12170269 1554:12093983 1513:34465416 1505:16503881 1464:21412583 1456:15789957 1358:20053543 1317:32212422 1260:24176681 1211:37156455 1203:24247849 1119:12972490 1070:11592375 1029:17665483 988:19686597 937:12480664 888:19880202 853:23558043 818:35519046 810:21992156 726:22350526 451:Migraine 349:tinnitus 244:Epilepsy 230:Diabetes 184:Chronic 22:medicine 6790:3437754 6575:1954680 6526:1754880 6177:3610124 6126:3267519 5998:2546377 5829:3551223 5740:9291857 5532:6838286 5391:7459469 5263:9406164 5035:7841967 4653:1758256 4569:9523496 4146:6394744 4138:1939874 4103:9368557 4068:1200192 4059:1776251 4010:3960993 3961:3943705 3878:1593914 3689:3989783 3680:1960139 3648:3746178 3639:1052513 3599:6973203 3470:3842710 3320:9343802 3275:1253643 3267:9330551 3194:2153470 3142:3929769 3067:3389599 2660:8348900 2524:2018694 2037:2649068 1995:8171351 1960:6498018 1916:9460955 1308:7096190 1251:6983582 1168:1549827 1110:1754338 979:2745808 928:1754293 775:7829785 622:"ACQLI" 464:nadolol 271:Fatigue 265:uveitis 42:surveys 6797: 6787: 6752: 6711: 6703: 6635: 6582: 6572: 6533: 6523: 6484: 6476: 6352: 6344: 6305: 6297: 6262: 6227: 6184: 6174: 6160:: 31. 6133: 6123: 6056: 6048: 6005: 5995: 5981:: 65. 5954: 5913: 5836: 5826: 5787: 5746: 5738: 5694: 5686: 5571: 5530: 5522: 5424: 5389: 5381: 5346: 5338: 5302: 5261: 5253: 5218: 5210: 5175: 5167: 5126: 5090: 5082: 5041: 5033: 4998: 4990: 4954: 4913: 4905: 4870: 4829: 4793: 4785: 4746: 4738: 4703: 4695: 4660: 4650: 4611: 4575: 4567: 4499: 4458: 4384: 4376: 4341: 4300: 4292: 4251: 4243: 4195: 4188:293474 4185: 4171:: 54. 4144: 4136: 4101: 4083:Stroke 4066: 4056: 4017: 4007: 3968: 3958: 3919: 3884: 3876: 3837:. RAND 3815: 3807: 3772: 3764: 3728: 3687: 3677: 3646: 3636: 3597: 3562: 3527: 3519: 3477: 3467: 3396: 3361: 3326: 3318: 3300: 3273: 3265: 3227: 3192: 3184: 3149: 3139: 3074: 3064: 3025: 3017: 2982: 2974: 2938: 2903: 2867: 2826: 2818: 2785:566487 2783: 2775: 2739: 2731: 2666: 2658: 2623: 2616:181153 2613: 2574: 2531: 2521: 2507:: 43. 2480: 2445: 2418: 2383: 2375: 2340: 2279: 2244: 2236: 2200: 2192: 2149: 2141: 2095: 2087: 2044: 2034: 2020:: 11. 1993: 1958: 1950: 1914: 1787: 1779: 1744: 1736: 1634: 1593: 1552: 1511: 1503: 1462: 1454: 1356: 1315: 1305: 1297: 1258: 1248: 1209: 1201: 1166: 1159:463574 1156: 1138:Thorax 1117: 1107: 1068: 1027: 986: 976: 935: 925: 886: 851: 816: 808: 773: 732: 724: 576:. The 562:. The 544:. The 526:. The 516:. The 476:. The 453:. The 273:. The 232:. The 210:. The 104:Asthma 88:. The 64:Angina 30:trials 6709:S2CID 6482:S2CID 6408:(PDF) 6397:(PDF) 6350:S2CID 6303:S2CID 6244:Chest 6054:S2CID 5744:S2CID 5692:S2CID 5528:S2CID 5422:S2CID 5387:S2CID 5344:S2CID 5259:S2CID 5216:S2CID 5173:S2CID 5088:S2CID 5039:S2CID 4996:S2CID 4911:S2CID 4791:S2CID 4744:S2CID 4701:S2CID 4573:S2CID 4382:S2CID 4298:S2CID 4249:S2CID 4142:S2CID 3882:S2CID 3813:S2CID 3770:S2CID 3525:S2CID 3324:S2CID 3271:S2CID 3190:S2CID 3023:S2CID 2984:50961 2980:S2CID 2824:S2CID 2781:S2CID 2737:S2CID 2664:S2CID 2381:S2CID 2242:S2CID 2198:S2CID 2170:(PDF) 2147:S2CID 2093:S2CID 1956:S2CID 1834:with 1785:S2CID 1742:S2CID 1509:S2CID 1460:S2CID 1376:(PDF) 1207:S2CID 814:S2CID 730:S2CID 625:(PDF) 592:Scars 309:EQ-5D 6795:PMID 6750:PMID 6701:PMID 6633:PMID 6580:PMID 6531:PMID 6474:PMID 6442:2013 6416:2013 6380:2013 6342:PMID 6295:PMID 6260:PMID 6225:PMID 6182:PMID 6131:PMID 6084:2013 6046:PMID 6003:PMID 5952:PMID 5911:PMID 5874:2013 5834:PMID 5785:PMID 5736:PMID 5684:PMID 5651:2013 5625:2013 5599:2013 5569:PMID 5520:PMID 5488:2013 5457:2013 5379:PMID 5336:PMID 5300:PMID 5251:PMID 5208:PMID 5165:PMID 5124:PMID 5080:PMID 5031:PMID 4988:PMID 4952:PMID 4903:PMID 4868:PMID 4827:PMID 4783:PMID 4736:PMID 4693:PMID 4658:PMID 4609:PMID 4565:PMID 4497:PMID 4456:PMID 4374:PMID 4339:PMID 4290:PMID 4241:PMID 4193:PMID 4134:PMID 4099:PMID 4064:PMID 4015:PMID 3966:PMID 3917:PMID 3874:PMID 3843:2013 3805:PMID 3762:PMID 3726:PMID 3685:PMID 3644:PMID 3595:PMID 3560:PMID 3544:Bone 3517:PMID 3475:PMID 3428:2013 3394:PMID 3359:PMID 3316:PMID 3263:PMID 3225:ISBN 3182:PMID 3147:PMID 3102:2013 3072:PMID 3015:PMID 2972:PMID 2936:PMID 2901:PMID 2865:PMID 2816:PMID 2773:PMID 2729:PMID 2694:2013 2656:PMID 2621:PMID 2572:PMID 2529:PMID 2478:PMID 2443:PMID 2416:PMID 2373:PMID 2338:PMID 2307:2013 2277:PMID 2234:PMID 2190:PMID 2139:PMID 2085:PMID 2042:PMID 1991:PMID 1948:PMID 1912:PMID 1777:PMID 1734:PMID 1632:PMID 1591:PMID 1550:PMID 1501:PMID 1452:PMID 1388:2013 1354:PMID 1313:PMID 1295:ISSN 1283:2020 1256:PMID 1199:PMID 1164:PMID 1115:PMID 1066:PMID 1025:PMID 984:PMID 933:PMID 884:PMID 849:PMID 806:PMID 771:PMID 722:PMID 637:2013 584:and 534:and 506:and 484:and 466:and 417:The 354:The 347:for 331:The 324:for 320:and 307:The 263:and 222:and 155:and 143:The 118:The 96:and 78:and 74:and 48:List 6785:PMC 6777:doi 6740:doi 6693:doi 6664:doi 6625:doi 6621:125 6570:PMC 6562:doi 6521:PMC 6513:doi 6466:doi 6334:doi 6330:149 6287:doi 6252:doi 6248:134 6217:doi 6213:149 6172:PMC 6162:doi 6121:PMC 6111:doi 6038:doi 5993:PMC 5983:doi 5942:doi 5901:doi 5861:doi 5824:PMC 5816:doi 5775:doi 5726:doi 5676:doi 5559:doi 5512:doi 5482:(1) 5414:doi 5371:doi 5328:doi 5290:doi 5243:doi 5200:doi 5155:doi 5116:doi 5070:doi 5023:doi 4980:doi 4942:doi 4895:doi 4858:doi 4819:doi 4775:doi 4728:doi 4685:doi 4648:PMC 4640:doi 4601:doi 4557:doi 4528:doi 4487:doi 4446:doi 4413:doi 4366:doi 4329:doi 4325:210 4280:doi 4231:doi 4183:PMC 4173:doi 4126:doi 4091:doi 4054:PMC 4046:doi 4005:PMC 3997:doi 3956:PMC 3948:doi 3909:doi 3866:doi 3797:doi 3793:120 3754:doi 3716:doi 3675:PMC 3634:PMC 3626:doi 3587:doi 3552:doi 3509:doi 3465:PMC 3455:doi 3386:doi 3351:doi 3308:doi 3255:doi 3217:doi 3174:doi 3137:PMC 3129:doi 3062:PMC 3054:doi 3007:doi 2964:doi 2928:doi 2893:doi 2855:doi 2851:119 2808:doi 2765:doi 2721:doi 2648:doi 2611:PMC 2603:doi 2564:doi 2519:PMC 2509:doi 2470:doi 2408:doi 2365:doi 2330:doi 2269:doi 2226:doi 2182:doi 2129:hdl 2121:doi 2077:doi 2073:273 2032:PMC 2022:doi 1983:doi 1940:doi 1902:doi 1869:doi 1819:doi 1808:doi 1769:doi 1765:167 1726:doi 1722:303 1696:doi 1663:doi 1622:doi 1581:doi 1577:110 1540:doi 1536:110 1491:doi 1444:doi 1415:doi 1344:doi 1340:104 1303:PMC 1287:doi 1246:PMC 1238:doi 1191:doi 1187:163 1154:PMC 1146:doi 1105:PMC 1097:doi 1056:doi 1015:doi 974:PMC 964:doi 923:PMC 915:doi 876:doi 872:147 841:doi 837:112 798:doi 761:doi 714:doi 298:HIV 40:or 6814:: 6793:. 6783:. 6771:. 6748:. 6736:52 6734:. 6730:. 6707:. 6699:. 6689:68 6687:. 6660:12 6658:. 6654:. 6631:. 6619:. 6578:. 6568:. 6558:66 6556:. 6552:. 6529:. 6519:. 6509:63 6507:. 6503:. 6480:. 6472:. 6462:39 6460:. 6432:. 6399:. 6370:. 6348:. 6340:. 6328:. 6301:. 6293:. 6283:44 6281:. 6258:. 6246:. 6223:. 6211:. 6180:. 6170:. 6158:11 6156:. 6152:. 6129:. 6119:. 6105:. 6101:. 6074:. 6052:. 6044:. 6034:15 6032:. 6001:. 5991:. 5977:. 5973:. 5950:. 5938:49 5936:. 5932:. 5909:. 5897:52 5895:. 5891:. 5855:. 5832:. 5822:. 5812:72 5810:. 5806:. 5783:. 5771:52 5769:. 5765:. 5742:. 5734:. 5722:36 5720:. 5716:. 5704:^ 5690:. 5682:. 5672:19 5670:. 5641:. 5615:. 5589:. 5567:. 5555:59 5553:. 5549:. 5526:. 5518:. 5508:19 5506:. 5480:80 5478:. 5474:. 5443:. 5420:. 5410:18 5408:. 5385:. 5377:. 5367:15 5365:. 5342:. 5334:. 5324:28 5322:. 5298:. 5286:29 5284:. 5280:. 5257:. 5249:. 5239:27 5237:. 5214:. 5206:. 5196:40 5194:. 5171:. 5163:. 5151:19 5149:. 5145:. 5122:. 5112:44 5110:. 5086:. 5078:. 5066:37 5064:. 5060:. 5037:. 5029:. 5017:. 4994:. 4986:. 4976:17 4974:. 4950:. 4938:90 4936:. 4932:. 4909:. 4901:. 4891:49 4889:. 4866:. 4854:13 4852:. 4848:. 4825:. 4815:21 4813:. 4789:. 4781:. 4771:52 4769:. 4756:^ 4742:. 4734:. 4724:12 4722:. 4699:. 4691:. 4679:. 4656:. 4646:. 4636:75 4634:. 4630:. 4607:. 4597:43 4595:. 4571:. 4563:. 4551:. 4524:14 4522:. 4518:. 4495:. 4483:12 4481:. 4477:. 4454:. 4442:12 4440:. 4436:. 4407:. 4403:. 4380:. 4372:. 4362:19 4360:. 4337:. 4323:. 4319:. 4296:. 4288:. 4276:40 4274:. 4270:. 4247:. 4239:. 4227:33 4225:. 4221:. 4191:. 4181:. 4167:. 4163:. 4140:. 4132:. 4122:17 4120:. 4097:. 4087:28 4085:. 4062:. 4052:. 4042:65 4040:. 4036:. 4013:. 4003:. 3993:25 3991:. 3987:. 3964:. 3954:. 3944:22 3942:. 3938:. 3915:. 3905:14 3903:. 3880:. 3872:. 3862:30 3860:. 3833:. 3811:. 3803:. 3791:. 3768:. 3760:. 3750:75 3748:. 3724:. 3712:27 3710:. 3706:. 3683:. 3671:35 3669:. 3665:. 3642:. 3632:. 3622:40 3620:. 3616:. 3593:. 3583:15 3581:. 3558:. 3548:59 3546:. 3523:. 3515:. 3505:15 3503:. 3473:. 3463:. 3451:11 3449:. 3445:. 3414:. 3392:. 3382:37 3380:. 3357:. 3347:51 3345:. 3322:. 3314:. 3306:. 3294:17 3292:. 3269:. 3261:. 3249:. 3223:. 3211:. 3188:. 3180:. 3170:25 3168:. 3145:. 3135:. 3123:. 3119:. 3092:. 3070:. 3060:. 3050:21 3048:. 3044:. 3021:. 3013:. 3003:15 3001:. 2978:. 2970:. 2960:22 2958:. 2934:. 2924:49 2922:. 2899:. 2889:52 2887:. 2863:. 2849:. 2845:. 2822:. 2814:. 2804:24 2802:. 2779:. 2771:. 2761:27 2759:. 2735:. 2727:. 2717:38 2715:. 2711:. 2684:. 2662:. 2654:. 2644:34 2642:. 2619:. 2609:. 2597:. 2593:. 2570:. 2560:67 2558:. 2527:. 2517:. 2503:. 2499:. 2476:. 2466:36 2464:. 2439:31 2437:. 2414:. 2404:22 2402:. 2379:. 2371:. 2361:40 2359:. 2336:. 2326:45 2297:. 2275:. 2265:50 2263:. 2240:. 2232:. 2222:46 2220:. 2196:. 2188:. 2178:40 2176:. 2172:. 2145:. 2137:. 2127:. 2117:44 2115:. 2091:. 2083:. 2071:. 2040:. 2030:. 2016:. 2012:. 1989:. 1979:38 1977:. 1954:. 1946:. 1936:14 1934:. 1910:. 1898:80 1896:. 1892:. 1863:. 1859:. 1806:. 1783:. 1775:. 1763:. 1740:. 1732:. 1720:. 1690:. 1686:. 1657:. 1653:. 1630:. 1618:15 1616:. 1612:. 1589:. 1575:. 1571:. 1548:. 1534:. 1530:. 1507:. 1499:. 1487:20 1485:. 1481:. 1458:. 1450:. 1440:14 1438:. 1409:. 1405:. 1378:. 1352:. 1338:. 1334:. 1311:. 1301:. 1293:. 1281:. 1277:. 1254:. 1244:. 1234:46 1232:. 1228:. 1205:. 1197:. 1185:. 1162:. 1152:. 1142:47 1140:. 1136:. 1113:. 1103:. 1093:62 1091:. 1087:. 1064:. 1052:44 1050:. 1046:. 1023:. 1011:57 1009:. 1005:. 982:. 972:. 960:11 958:. 954:. 931:. 921:. 911:62 909:. 905:. 882:. 870:. 847:. 835:. 812:. 804:. 794:14 792:. 769:. 757:25 755:. 751:. 728:. 720:. 710:29 708:. 627:. 502:, 429:. 389:, 366:, 339:, 316:, 293:). 256:, 218:, 70:, 24:, 6801:. 6779:: 6756:. 6742:: 6715:. 6695:: 6672:. 6666:: 6639:. 6627:: 6586:. 6564:: 6537:. 6515:: 6488:. 6468:: 6444:. 6418:. 6382:. 6356:. 6336:: 6309:. 6289:: 6266:. 6254:: 6231:. 6219:: 6188:. 6164:: 6137:. 6113:: 6107:6 6086:. 6060:. 6040:: 6009:. 5985:: 5979:6 5958:. 5944:: 5917:. 5903:: 5876:. 5863:: 5840:. 5818:: 5791:. 5777:: 5750:. 5728:: 5698:. 5678:: 5653:. 5627:. 5601:. 5575:. 5561:: 5534:. 5514:: 5490:. 5459:. 5428:. 5416:: 5393:. 5373:: 5350:. 5330:: 5306:. 5292:: 5265:. 5245:: 5222:. 5202:: 5179:. 5157:: 5130:. 5118:: 5094:. 5072:: 5045:. 5025:: 5019:3 5002:. 4982:: 4958:. 4944:: 4917:. 4897:: 4874:. 4860:: 4833:. 4821:: 4797:. 4777:: 4750:. 4730:: 4707:. 4687:: 4681:8 4664:. 4642:: 4615:. 4603:: 4579:. 4559:: 4553:7 4536:. 4530:: 4503:. 4489:: 4462:. 4448:: 4421:. 4415:: 4409:6 4388:. 4368:: 4345:. 4331:: 4304:. 4282:: 4255:. 4233:: 4199:. 4175:: 4169:1 4148:. 4128:: 4105:. 4093:: 4070:. 4048:: 4021:. 3999:: 3972:. 3950:: 3923:. 3911:: 3888:. 3868:: 3845:. 3819:. 3799:: 3776:. 3756:: 3732:. 3718:: 3691:. 3650:. 3628:: 3601:. 3589:: 3566:. 3554:: 3531:. 3511:: 3481:. 3457:: 3430:. 3400:. 3388:: 3365:. 3353:: 3330:. 3310:: 3277:. 3257:: 3251:6 3233:. 3219:: 3196:. 3176:: 3153:. 3131:: 3125:7 3104:. 3078:. 3056:: 3029:. 3009:: 2986:. 2966:: 2942:. 2930:: 2907:. 2895:: 2871:. 2857:: 2830:. 2810:: 2787:. 2767:: 2743:. 2723:: 2696:. 2670:. 2650:: 2627:. 2605:: 2599:3 2578:. 2566:: 2535:. 2511:: 2505:7 2484:. 2472:: 2449:. 2422:. 2410:: 2387:. 2367:: 2344:. 2332:: 2309:. 2283:. 2271:: 2248:. 2228:: 2204:. 2184:: 2153:. 2131:: 2123:: 2099:. 2079:: 2048:. 2024:: 2018:9 1997:. 1985:: 1962:. 1942:: 1918:. 1904:: 1877:. 1871:: 1865:9 1844:) 1842:. 1821:: 1814:. 1810:: 1791:. 1771:: 1748:. 1728:: 1704:. 1698:: 1692:6 1671:. 1665:: 1659:8 1638:. 1624:: 1597:. 1583:: 1556:. 1542:: 1515:. 1493:: 1466:. 1446:: 1423:. 1417:: 1411:8 1390:. 1360:. 1346:: 1319:. 1289:: 1262:. 1240:: 1213:. 1193:: 1170:. 1148:: 1121:. 1099:: 1072:. 1058:: 1031:. 1017:: 990:. 966:: 939:. 917:: 890:. 878:: 855:. 843:: 820:. 800:: 777:. 763:: 736:. 716:: 639:. 588:. 556:. 538:. 510:. 414:. 401:. 374:. 351:. 328:. 283:. 267:. 226:. 159:. 130:. 106:. 100:. 82:.

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.